Document And Entity Information
Document And Entity Information - shares | 6 Months Ended | |
Mar. 31, 2017 | Apr. 28, 2017 | |
Entity Registrant Name | Dolby Laboratories, Inc. | |
Entity Central Index Key | 1,308,547 | |
Current Fiscal Year End Date | --09-29 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2017 | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false | |
Class A Common Stock [Member] | ||
Entity Common Stock, Shares Outstanding | 57,958,551 | |
Class B Common Stock [Member] | ||
Entity Common Stock, Shares Outstanding | 44,073,597 |
Interim Condensed Consolidated
Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Current assets: | ||
Cash and cash equivalents | $ 532,508 | $ 516,112 |
Restricted cash | 5,752 | 3,645 |
Short-term investments | 194,997 | 121,629 |
Accounts receivable, net of allowance for doubtful accounts of $3,258 and $2,370 | 88,216 | 75,688 |
Inventories | 17,697 | 16,354 |
Prepaid expenses and other current assets | 32,501 | 26,302 |
Total current assets | 871,671 | 759,730 |
Long-term investments | 326,800 | 393,904 |
Property, plant and equipment, net | 471,095 | 443,656 |
Intangible assets, net | 203,723 | 215,342 |
Goodwill | 308,751 | 309,616 |
Deferred taxes | 176,288 | 166,790 |
Other non-current assets | 29,469 | 21,068 |
Total assets | 2,387,797 | 2,310,106 |
Current liabilities: | ||
Accounts payable | 10,062 | 17,544 |
Accrued liabilities | 179,029 | 169,055 |
Income taxes payable | 25 | 2,304 |
Deferred revenue | 23,940 | 24,180 |
Total current liabilities | 213,056 | 213,083 |
Long-term deferred revenue | 35,651 | 35,366 |
Other non-current liabilities | 95,932 | 82,922 |
Total liabilities | 344,639 | 331,371 |
Stockholders' equity: | ||
Additional paid-in capital | 37,459 | 42,032 |
Retained earnings | 2,013,790 | 1,938,320 |
Accumulated other comprehensive (loss) | (14,708) | (10,197) |
Total stockholders’ equity – Dolby Laboratories, Inc. | 2,036,642 | 1,970,256 |
Controlling interest | 6,516 | 8,479 |
Total stockholders’ equity | 2,043,158 | 1,978,735 |
Total liabilities and stockholders’ equity | 2,387,797 | 2,310,106 |
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 57,702,863 shares issued and outstanding at March 31, 2017 and 57,018,362 at September 30, 2016 | ||
Stockholders' equity: | ||
Common stock | 57 | 57 |
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 44,073,597 shares issued and outstanding at March 31, 2017 and 44,403,847 at September 30, 2016 | ||
Stockholders' equity: | ||
Common stock | $ 44 | $ 44 |
Interim Condensed Consolidated3
Interim Condensed Consolidated Balance Sheets (Parenthetical) $ in Thousands | Mar. 31, 2017USD ($)vote / shares$ / sharesshares | Sep. 30, 2016USD ($)vote / shares$ / sharesshares |
Allowance for doubtful accounts | $ | $ (3,258) | $ (2,370) |
Class A Common Stock [Member] | ||
Common stock, par value (usd per share) | $ / shares | $ 0.001 | $ 0.001 |
Common stock voting right per share (votes per share) | vote / shares | 1 | 1 |
Common stock, shares authorized (shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (shares) | 57,702,863 | 57,018,362 |
Common stock, shares outstanding (shares) | 57,702,863 | 57,018,362 |
Class B Common Stock [Member] | ||
Common stock, par value (usd per share) | $ / shares | $ 0.001 | $ 0.001 |
Common stock voting right per share (votes per share) | vote / shares | 10 | 10 |
Common stock, shares authorized (shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (shares) | 44,073,597 | 44,403,847 |
Common stock, shares outstanding (shares) | 44,073,597 | 44,403,847 |
Interim Condensed Consolidated4
Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Revenue: | ||||
Products | $ 20,713 | $ 20,063 | $ 48,924 | $ 44,872 |
Services | 5,144 | 4,941 | 10,501 | 9,817 |
Total revenue | 267,474 | 274,340 | 533,741 | 515,154 |
Cost of revenue: | ||||
Cost of products | 13,988 | 13,978 | 31,708 | 33,016 |
Cost of services | 4,193 | 3,697 | 8,319 | 7,892 |
Total cost of revenue | 26,977 | 24,373 | 56,944 | 54,139 |
Gross margin | 240,497 | 249,967 | 476,797 | 461,015 |
Operating expenses: | ||||
Research and development | 58,341 | 52,088 | 115,859 | 105,416 |
Sales and marketing | 75,620 | 71,815 | 146,795 | 146,269 |
General and administrative | 43,253 | 42,482 | 84,793 | 86,560 |
Restructuring charges | 0 | 1,255 | 0 | 1,255 |
Total operating expenses | 177,214 | 167,640 | 347,447 | 339,500 |
Operating income | 63,283 | 82,327 | 129,350 | 121,515 |
Other income/expense: | ||||
Interest income | 1,250 | 4,000 | 2,547 | |
Interest expense | (37) | (33) | (63) | (62) |
Other income/(expense), net | 762 | 279 | 563 | (693) |
Total other income | 2,911 | 1,496 | 4,500 | 1,792 |
Income before income taxes | 66,194 | 83,823 | 133,850 | 123,307 |
Provision for income taxes | (15,467) | (16,278) | (29,549) | (24,751) |
Net income including controlling interest | 50,727 | 67,545 | 104,301 | 98,556 |
Less: net (income) attributable to controlling interest | (137) | (147) | (337) | (257) |
Net income attributable to Dolby Laboratories, Inc. | $ 50,590 | $ 67,398 | $ 103,964 | $ 98,299 |
Net income per share: | ||||
Basic (in usd per share) | $ 0.50 | $ 0.67 | $ 1.02 | $ 0.98 |
Diluted (in usd per share) | $ 0.49 | $ 0.66 | $ 1 | $ 0.97 |
Weighted-average shares outstanding: | ||||
Basic (in shares) | 101,787 | 100,456 | 101,635 | 100,600 |
Diluted (in shares) | 103,883 | 101,555 | 103,867 | 101,716 |
Related party rent expense: | ||||
Included in operating expenses | $ 793 | $ 756 | $ 1,575 | $ 1,537 |
Included in net income attributable to controlling interest | $ 175 | $ 174 | $ 350 | $ 350 |
Common stock, dividends declared (in dollars per share) | $ 0.14 | $ 0.12 | $ 0.28 | $ 0.24 |
Common Stock, Dividends, Per Share, Cash Paid | $ 0.14 | $ 0.12 | $ 0.28 | $ 0.24 |
Interim Condensed Consolidated5
Interim Condensed Consolidated Statements of Comprehensive Income Statement - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income including controlling interest | $ 50,727 | $ 67,545 | $ 104,301 | $ 98,556 |
Other comprehensive income: | ||||
Foreign currency translation adjustments, net of tax | 4,445 | 2,872 | (3,279) | 2,122 |
Unrealized gains/(losses) on available-for-sale securities, net of tax | 581 | 1,563 | (1,438) | 703 |
Comprehensive income | 55,753 | 71,980 | 99,584 | 101,381 |
Less: comprehensive (income) attributable to controlling interest | (192) | (1) | (131) | 38 |
Comprehensive income attributable to Dolby Laboratories, Inc. | $ 55,561 | $ 71,979 | $ 99,453 | $ 101,419 |
Interim Condensed Consolidated6
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock [Member] | Additional Paid-In Capital [Member] | Retained Earnings [Member] | Accumulated Other Comprehensive Income [Member] | Total Dolby Laboratories,Inc.[Member] | Controlling Interest [Member] |
Beginning balance at Sep. 25, 2015 | $ 1,816,007 | $ 102 | $ 17,571 | $ 1,800,857 | $ (11,462) | $ 1,807,068 | $ 8,939 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 98,556 | 98,299 | 98,299 | 257 | |||
Translation adjustments, net of tax of $829 and $(64), respectively | 2,122 | 2,417 | 2,417 | (295) | |||
Unrealized gains (losses) on available-for-sale securities, net of tax of $(327) and $(98), respectively | 703 | 703 | 703 | ||||
Distributions to controlling interest | (214) | (214) | |||||
Stock-based compensation expense | 35,466 | 35,466 | 35,466 | ||||
Repurchase of common stock | (76,856) | (2) | (55,500) | 21,354 | (76,856) | ||
Cash dividends declared and paid on common stock | (24,200) | (24,200) | (24,200) | ||||
Tax benefit/(deficiency) from the stock incentive plans | (1,369) | (1,369) | (1,369) | ||||
Common stock issued under employee stock plans | 14,575 | 0 | 14,575 | 14,575 | |||
Tax withholdings on vesting of restricted stock | (10,742) | (1) | (10,743) | (10,742) | |||
Ending balance at Apr. 01, 2016 | 1,854,048 | 101 | 0 | 1,853,602 | (8,342) | 1,845,361 | 8,687 |
Beginning balance at Sep. 30, 2016 | 1,978,735 | 101 | 42,032 | 1,938,320 | (10,197) | 1,970,256 | 8,479 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 104,301 | 103,964 | 103,964 | 337 | |||
Translation adjustments, net of tax of $829 and $(64), respectively | (3,279) | (3,073) | (3,073) | (206) | |||
Unrealized gains (losses) on available-for-sale securities, net of tax of $(327) and $(98), respectively | (1,438) | (1,438) | (1,438) | ||||
Distributions to controlling interest | (2,094) | 0 | (2,094) | ||||
Stock-based compensation expense | 33,198 | 33,198 | 33,198 | ||||
Repurchase of common stock | (50,000) | (1) | (49,999) | 0 | (50,000) | ||
Cash dividends declared and paid on common stock | (28,494) | (28,494) | (28,494) | ||||
Tax benefit/(deficiency) from the stock incentive plans | 3,818 | 3,818 | 3,818 | ||||
Common stock issued under employee stock plans | 24,210 | 2 | 24,208 | 24,210 | |||
Tax withholdings on vesting of restricted stock | (15,799) | (1) | (15,798) | (15,799) | |||
Ending balance at Mar. 31, 2017 | $ 2,043,158 | $ 101 | $ 37,459 | $ 2,013,790 | $ (14,708) | $ 2,036,642 | $ 6,516 |
Interim Condensed Consolidated7
Interim Condensed Consolidated Statements Of Stockholders' Equity (Parenthetical) - USD ($) $ in Thousands | 6 Months Ended | |
Mar. 31, 2017 | Apr. 01, 2016 | |
Statement of Stockholders' Equity [Abstract] | ||
Foreign currency translation tax | $ 1,265 | $ 343 |
Unrealized gains (losses) on available-for-sale securities, tax | $ 95 | $ 168 |
Interim Condensed Consolidated8
Interim Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Mar. 31, 2017 | Apr. 01, 2016 | |
Operating activities: | ||
Net income including controlling interest | $ 104,301 | $ 98,556 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 44,061 | 42,917 |
Stock-based compensation | 33,198 | 35,466 |
Amortization of premium on investments | 1,376 | 2,661 |
Excess tax benefit from exercise of stock options | (3,981) | (338) |
Provision for doubtful accounts | 1,010 | 1,228 |
Deferred income taxes | (8,856) | (5,709) |
Other non-cash items affecting net income | 160 | 498 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (13,538) | (1,727) |
Inventories | (3,253) | (3,533) |
Prepaid expenses and other assets | (11,280) | (6,979) |
Accounts payable and other liabilities | 495 | (5,939) |
Income taxes, net | 11,089 | (8,752) |
Deferred revenue | 85 | 8,495 |
Other non-current liabilities | 480 | 22 |
Net cash provided by operating activities | 155,347 | 156,866 |
Investing activities: | ||
Purchase of investments | (98,789) | (200,944) |
Proceeds from sales of investment securities | 23,071 | 227,094 |
Proceeds from maturities of investment securities | 66,171 | 59,053 |
Purchases of property, plant and equipment | (51,230) | (48,984) |
Purchases of intangible assets | (5,250) | (105,270) |
Change in restricted cash | (2,107) | (2,342) |
Net cash provided by/(used in) investing activities | (68,134) | (71,393) |
Financing activities: | ||
Proceeds from issuance of common stock | 24,210 | 14,575 |
Repurchase of common stock | (50,000) | (76,856) |
Payment of cash dividend | (28,494) | (24,200) |
Distribution to controlling interest | (2,094) | (214) |
Excess tax benefit from the exercise of stock options | 3,981 | 338 |
Shares repurchased for tax withholdings on vesting of restricted stock | (15,799) | (10,742) |
Net cash used in financing activities | (68,196) | (97,099) |
Effect of foreign exchange rate changes on cash and cash equivalents | (2,621) | 902 |
Net increase/(decrease) in cash and cash equivalents | 16,396 | (10,724) |
Cash and cash equivalents at beginning of period | 516,112 | 531,926 |
Cash and cash equivalents at end of period | 532,508 | 521,202 |
Supplemental disclosure: | ||
Cash paid for income taxes, net of refunds received | 28,093 | 39,227 |
Increase/(decrease) in PP&E purchases unpaid at period-end | (2,248) | (9,592) |
Noncash or Part Noncash Acquisition, Consideration Payable | $ 0 | $ 95 |
Basis Of Presentation
Basis Of Presentation | 6 Months Ended |
Mar. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis Of Presentation | 1 . Basis of Presentation Unaudited Interim Condensed Consolidated Financial Statements We have prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with U.S. GAAP, and with SEC rules and regulations, which allow for certain information and footnote disclosures that are normally included in annual financial statements prepared in accordance with U.S. GAAP to be condensed or omitted. In our opinion, these unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements for the fiscal year ended September 30, 2016 and include all adjustments necessary for fair presentation. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with our consolidated financial statements for the fiscal year ended September 30, 2016 , which are included in our Annual Report on Form 10-K filed with the SEC. The results for the fiscal quarter ended March 31, 2017 are not necessarily indicative of the results to be expected for any subsequent quarterly or annual financial period, including the fiscal year ending September 29, 2017 . Principles of Consolidation The unaudited interim condensed consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder has a controlling interest. We report these controlling interests as a separate line in our consolidated statements of operations as net income attributable to controlling interest and in our consolidated balance sheets as a controlling interest. We eliminate all intercompany accounts and transactions upon consolidation. Operating Segments We operate as a single reportable segment. During the fiscal quarter ended December 30, 2016, we reorganized certain aspects of our internal business infrastructure primarily to integrate and align sales support more directly with our business units. Following the reorganization, we reassessed our business units and concluded that the composition of our reportable segments remains unchanged and that we continue to operate as a single reportable segment. This reflects the fact that our CODM, our Chief Executive Officer, continues to evaluate our financial information and resources, and continues to assess the performance of these resources, on a consolidated basis. All required financial segment information is therefore included in our unaudited interim condensed consolidated financial statements. Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our unaudited interim condensed consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated selling prices for elements sold in ME revenue arrangements; valuation allowances for accounts receivable; carrying values of inventories and certain property, plant, and equipment, goodwill and intangible assets; fair values of investments; accrued liabilities including liabilities for unrecognized tax benefits, deferred income tax assets and liabilities and stock-based compensation. Actual results could differ from our estimates. Fiscal Year Our fiscal year is a 52 or 53 week period ending on the last Friday in September. The fiscal periods presented herein include the 13 week period ended March 31, 2017 and the 14 week period ended April 1, 2016 . Our fiscal year ended September 30, 2016 (fiscal 2016 ) consisted of 53 weeks while our fiscal year ending September 29, 2017 (fiscal 2017 ) will consist of 52 weeks. |
Summary Of Significant Accounti
Summary Of Significant Accounting Policies | 6 Months Ended |
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2 . Summary of Significant Accounting Policies We continually assess any ASUs or other new accounting pronouncements issued by the FASB to determine their applicability and impact on us. Where it is determined that a new accounting pronouncement will result in a change to our financial reporting, we take the appropriate steps to ensure that such changes are properly reflected in our consolidated financial statements or notes thereto. Recently Issued Accounting Standards Adopted Standards Consolidation. During the first quarter of fiscal 2017, we adopted ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis , which amended the consolidation requirements in ASC 810 and significantly changed the consolidation analysis required under U.S. GAAP. The ASU significantly amended how variable interests held by a reporting entity’s related parties or de facto agents affect its consolidation conclusion. Adoption of this new standard did not result in any changes to the entities we currently consolidate and did not otherwise have any impact on our consolidated financial statements or notes thereto. Inventory. During the second quarter of fiscal 2017, we adopted ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory, which affected reporting entities that measure inventory using FIFO or average cost. Specifically, ASU 2015-11 requires that inventory be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using LIFO or the retail inventory method. Adoption of this new standard did not result in any material changes to inventory and did not otherwise have any impact on our consolidated financial statements or notes thereto. There have been no new accounting standards made effective or otherwise adopted during the current interim period that caused any changes to our significant accounting policies from those that were described in our Form 10-K for the prior fiscal year ended September 30, 2016 . Standards Not Yet Effective Revenue Recognition. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which outlines a comprehensive revenue recognition model and supersedes most current revenue recognition guidance. The new standard defines a five-step approach for recognizing revenue, which may require a company to use more judgment and make more estimates than under the current guidance. It requires an entity to, among others, recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers, recognize certain direct costs associated with revenues and contract acquisition costs such as sales commissions, and make expanded disclosures. We may adopt the new standard by either the full retrospective method whereby the standard is applied to all periods presented or the modified retrospective method whereby the cumulative effect of applying the new guidance is recognized as an adjustment to the opening retained earnings balance. We are evaluating the impact on all of our revenue streams and currently believe the most significant changes upon adoption will be as follows: • A change from recognizing our royalty-based revenue in the quarter it is reported to us by our licensees to estimating royalty-based revenue earned from our licensees’ shipments in the reporting period with subsequent adjustments recorded as the royalties are reported. • Capitalizing applicable sales commissions that are direct and incremental to obtaining a contract. • A decrease in our deferred revenue balances. We have not quantified the impact of the change in timing or the reduction in deferred revenue. We are currently evaluating our transition options. Although permitted, we do not intend to early-adopt the new standard, but we will adopt it beginning September 29, 2018. Leases. In February 2016, the FASB issued ASU 2016-02, Leases, which amends the existing accounting standards for leases. Under the new guidance, a lessee will be required to recognize a lease liability and right-of-use asset for all long-term leases, which are those with terms in excess of twelve months. The new guidance also modifies the classification criteria and accounting for sales-type and direct financing leases, and requires additional disclosures to enable users of financial statements to understand the amount, timing, and uncertainty of cash flows arising from leases. Consistent with current guidance, a lessee's recognition, measurement, and presentation of expenses and cash flows arising from a lease will continue to depend primarily on its classification. The ASU is effective for us beginning September 28, 2019, and must be applied using a modified retrospective approach. Early adoption is permitted, including adoption in an interim period. Upon adoption, we will recognize a lease liability and right-of-use asset for each of our long-term lease arrangements which currently exceed 40 as of the end of the second quarter of fiscal 2017 . We currently intend to early adopt this new standard concurrently with the adoption of the new revenue recognition standard beginning September 29, 2018. Share-Based Compensation . In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting , which simplifies several aspects of the accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory withholding requirements, as well as classification in the statement of cash flows. We will adopt the new standard beginning September 30, 2017. We are currently evaluating the impact of the standard on our consolidated financial statements. Going Concern. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern . ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards as specified in the guidance. The ASU is effective for us beginning September 29, 2018. Early adoption is permitted, including adoption in an interim period. We do not anticipate that the new standard will impact our consolidated financial statements. Cash Flow Classification. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments . The new guidance addresses eight specific cash flow issues, with the objective of reducing an existing diversity in practices regarding the manner in which certain cash receipts and payments are presented and classified in the statement of cash flows. The ASU is effective for us beginning September 29, 2018. Early adoption is permitted, including adoption in an interim period, and we are currently evaluating the timing and impact of the standard on our consolidated financial statements. Income Taxes: Intra-Entity Asset Transfers. In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory . The new guidance requires the recognition of the income tax consequences of an intercompany asset transfer, other than transfers of inventory, when the transfer occurs. For intercompany transfers of inventory, the income tax effects will continue to be deferred until the inventory has been sold to a third party. The ASU is effective for us beginning September 29, 2018. Early adoption is permitted, including adoption in an interim period, and we do not anticipate that the new standard will impact our consolidated financial statements. Restricted Cash. In November 2016, the FASB issued ASU 2016-18, Restricted Cash — a consensus of the FASB Emerging Issues Task Force , which clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows. The new guidance requires entities to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash flows. The ASU is effective for us beginning September 29, 2018. Early adoption is permitted, including adoption in an interim period. Aside from conforming to new cash flow presentation and restricted cash disclosure requirements, we do not anticipate that the new standard will impact our consolidated financial statements. |
Composition Of Certain Financia
Composition Of Certain Financial Statement Captions | 6 Months Ended |
Mar. 31, 2017 | |
Composition Of Certain Financial Statement Captions [Abstract] | |
Composition Of Certain Financial Statement Captions | 3 . Composition of Certain Financial Statement Captions The following tables present detailed information from our consolidated balance sheets as of March 31, 2017 and September 30, 2016 (amounts displayed in thousands, except as otherwise noted). Accounts Receivable March 31, September 30, Trade accounts receivable $ 78,755 $ 66,229 Accounts receivable from patent administration program customers 12,719 11,829 Accounts receivable, gross 91,474 78,058 Less: allowance for doubtful accounts (3,258 ) (2,370 ) Total $ 88,216 $ 75,688 Inventories March 31, September 30, Raw materials $ 3,934 $ 3,526 Work in process 3,236 4,020 Finished goods 10,527 8,808 Total $ 17,697 $ 16,354 Inventories are stated at the lower of cost and net realizable value. Inventory with a consumption period expected to exceed twelve months is recorded within other non-current assets in our consolidated balance sheets. In addition to the amounts shown in the table above, we have included $2.0 million and $1.6 million of raw materials inventory within other non-current assets in our consolidated balance sheets as of March 31, 2017 and September 30, 2016 , respectively. Based on anticipated inventory consumption rates, and aside from existing write-downs due to excess and obsolete inventory, we do not believe that material risk of obsolescence exists prior to ultimate sale. Prepaid Expenses And Other Current Assets March 31, September 30, Prepaid expenses $ 17,532 $ 13,440 Other current assets 10,510 11,578 Income tax receivable 4,459 1,284 Total $ 32,501 $ 26,302 Accrued Liabilities March 31, September 30, Accrued royalties $ 2,144 $ 1,939 Amounts payable to patent administration program partners 49,953 34,472 Accrued compensation and benefits 59,458 71,261 Accrued professional fees 7,896 6,528 Other accrued liabilities 59,578 54,855 Total $ 179,029 $ 169,055 Other accrued liabilities include amounts accrued for unpaid PP&E additions of $21.2 million and $17.1 million as of March 31, 2017 and September 30, 2016 , respectively. Other Non-Current Liabilities March 31, September 30, Supplemental retirement plan obligations $ 2,694 $ 2,540 Non-current tax liabilities 80,925 68,254 Other liabilities 12,313 12,128 Total $ 95,932 $ 82,922 |
Investments & Fair Value Measur
Investments & Fair Value Measurements | 6 Months Ended |
Mar. 31, 2017 | |
Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] | |
Investments & Fair Value Measurements | 4 . Investments & Fair Value Measurements We use cash holdings to purchase investment grade securities diversified among security types, industries and issuers. All of our investment securities are measured at fair value, and are recorded within cash equivalents and both short-term and long-term investments in our consolidated balance sheets. With the exception of our mutual fund investments held in our SERP and classified as trading securities, all of our investment securities are classified as AFS securities. Our investment securities primarily consist of municipal debt securities, corporate bonds, U.S. agency securities and commercial paper. In addition, our cash and cash equivalents also consist of highly-liquid money market funds. Consistent with our investment policy, none of our held municipal debt investments are supported by letters of credit or standby purchase agreements. Our cash and investment portfolio consists of the following (in thousands): March 31, 2017 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 522,850 $ 522,850 Cash equivalents: Money market funds 9,498 — — 9,498 9,498 Corporate bonds 160 — — 160 160 Cash and cash equivalents 532,508 — — 532,508 9,498 160 — Short-term investments: Certificate of deposit (1) 28,318 19 (6 ) 28,331 28,331 U.S. agency securities 2,715 — (3 ) 2,712 2,712 Commercial paper 15,353 5 (1 ) 15,357 15,357 Corporate bonds 127,350 48 (109 ) 127,289 127,289 Municipal debt securities 21,312 2 (6 ) 21,308 21,308 Short-term investments 195,048 74 (125 ) 194,997 2,712 192,285 — Long-term investments: Certificate of deposit (1) 6,230 — (2 ) 6,228 6,228 U.S. agency securities 24,809 — (217 ) 24,592 24,592 Government bonds 22,994 4 (197 ) 22,801 22,801 Corporate bonds 228,406 322 (795 ) 227,933 227,933 Municipal debt securities 41,592 52 (57 ) 41,587 41,587 Other long-term investments (2) 3,282 377 — 3,659 377 Long-term investments 327,313 755 (1,268 ) 326,800 47,770 275,748 — Total cash, cash equivalents, and investments $ 1,054,869 $ 829 $ (1,393 ) $ 1,054,305 $ 59,980 $ 468,193 $ — Investments held in supplemental retirement plan: Assets 2,792 2,792 2,792 Included in prepaid expenses and other current assets & other non-current assets Liabilities 2,792 2,792 2,792 Included in accrued liabilities & other non-current liabilities (1) Certificates of deposit include marketable securities, while those with a maturity in excess of one year as of March 31, 2017 are classified within long-term investments. (2) Other long-term investments as of March 31, 2017 include a marketable equity security of $0.4 million , and other investments that are not carried at fair value including an equity method investment of $0.8 million and two cost method investments of $2.0 million and $0.5 million . September 30, 2016 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 501,863 $ 501,863 Cash equivalents: Commercial paper 1,099 — — 1,099 1,099 Corporate bonds 2,240 — — 2,240 2,240 Money market funds 10,910 — — 10,910 10,910 Cash and cash equivalents 516,112 — — 516,112 10,910 3,339 — Short-term investments: Certificate of deposit (1) 13,912 6 — 13,918 13,918 Commercial paper 19,629 1 (10 ) 19,620 19,620 Corporate bonds 63,762 24 (14 ) 63,772 63,772 Municipal debt securities 24,334 — (15 ) 24,319 24,319 Short-term investments 121,637 31 (39 ) 121,629 — 121,629 — Long-term investments: Certificate of deposit (1) 4,500 10 — 4,510 4,510 U.S. agency securities 27,536 24 (26 ) 27,534 27,534 Government bonds 31,971 77 (12 ) 32,036 32,036 Corporate bonds 295,921 715 (266 ) 296,370 296,370 Municipal debt securities 30,090 28 (32 ) 30,086 30,086 Other long-term investments (2) 3,002 366 — 3,368 366 Long-term investments 393,020 1,220 (336 ) 393,904 59,936 330,966 — Total cash, cash equivalents, and investments $ 1,030,769 $ 1,251 $ (375 ) $ 1,031,645 $ 70,846 $ 455,934 $ — Investments held in supplemental retirement plan: Assets 2,638 2,638 2,638 Included in prepaid expenses and other current assets & other non-current assets Liabilities 2,638 2,638 2,638 Included in accrued liabilities & other non-current liabilities (1) Certificates of deposit include marketable securities, while those with a maturity in excess of one year as of September 30, 2016 are classified within long-term investments. (2) Other long-term investments as of September 30, 2016 include a marketable equity security of $0.4 million , and other investments that are not carried at fair value including an equity method investment of $0.5 million and two cost method investments of $2.0 million and $0.5 million . Fair Value Hierarchy. Fair value is the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. We minimize the use of unobservable inputs and use observable market data, if available, when determining fair value. We classify our inputs to measure fair value using the following three-level hierarchy: Level 1: Quoted prices in active markets at the measurement date for identical assets and liabilities. We base the fair value of our Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Level 2: Prices may be based upon quoted prices in active markets or inputs not quoted on active markets but are corroborated by market data. We obtain the fair value of our Level 2 financial instruments from a professional pricing service, which may use quoted market prices for identical or comparable instruments, or model driven valuations using observable market data or inputs corroborated by observable market data. To validate the fair value determination provided by our primary pricing service, we perform quality controls over values received which include comparing our pricing service provider’s assessment of the fair values of our investment securities against the fair values of our investment securities obtained from another independent source, reviewing the pricing movement in the context of overall market trends, and reviewing trading information from our investment managers. In addition, we assess the inputs and methods used in determining the fair value in order to determine the classification of securities in the fair value hierarchy. Level 3: Unobservable inputs are used when little or no market data is available and reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Securities In Gross Unrealized Loss Position. We periodically evaluate our investments for other-than- temporary declines in fair value. The unrealized losses on our AFS securities were primarily the result of unfavorable changes in interest rates subsequent to the initial purchase of these securities. The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for twelve months or greater as of March 31, 2017 and September 30, 2016 (in thousands): March 31, 2017 September 30, 2016 Less Than 12 Months 12 Months Or Greater Less Than 12 Months 12 Months Or Greater Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Certificate of deposit $ 14,412 $ (8 ) $ — $ — $ — $ — $ — $ — U.S. agency securities 27,304 (220 ) — — 22,988 (38 ) — — Government bonds 19,799 (197 ) — — — — — — Commercial paper 4,951 (1 ) — — 11,479 (10 ) — — Corporate bonds 212,903 (904 ) — — 153,491 (280 ) 1,000 — Municipal debt securities 33,902 (62 ) 1,250 (1 ) 35,625 (42 ) 4,615 (5 ) Total $ 313,271 $ (1,392 ) $ 1,250 $ (1 ) $ 223,583 $ (370 ) $ 5,615 $ (5 ) Although we had certain securities that were in an unrealized loss position as of March 31, 2017 , we expect to recover the full carrying value of these securities as we do not intend to, nor do we currently anticipate a need to sell these securities prior to recovering the associated unrealized losses. As a result, we do not consider any portion of the unrealized losses at either March 31, 2017 or September 30, 2016 to represent an other-than-temporary impairment, nor do we consider any of the unrealized losses to be credit losses. Investment Maturities. The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of March 31, 2017 and September 30, 2016 , which are recorded within cash equivalents and both short and long-term investments in our consolidated balance sheets (in thousands): March 31, 2017 September 30, 2016 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 204,708 $ 204,655 $ 135,886 $ 135,884 Due in 1 to 2 years 219,732 219,571 225,679 225,953 Due in 2 to 3 years 104,297 103,570 164,339 164,583 Total $ 528,737 $ 527,796 $ 525,904 $ 526,420 |
Property, Plant and Equipment
Property, Plant and Equipment | 6 Months Ended |
Mar. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | 5 . Property, Plant & Equipment Property, plant and equipment are recorded at cost, with depreciation expense included in cost of licensing, cost of products, cost of services, R&D, S&M and G&A expenses in our consolidated statements of operations. PP&E consist of the following (in thousands): March 31, September 30, Land $ 43,270 $ 43,325 Buildings and building improvements 276,916 251,700 Leasehold improvements 61,626 60,480 Machinery and equipment 94,917 88,943 Computer equipment and software 162,883 154,291 Furniture and fixtures 27,735 26,900 Equipment provided under operating leases 73,912 35,968 Construction-in-progress 6,520 32,576 Property, plant and equipment, gross 747,779 694,183 Less: accumulated depreciation (276,684 ) (250,527 ) Property, plant and equipment, net $ 471,095 $ 443,656 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 6 Months Ended |
Mar. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | 6 . Goodwill & Intangible Assets Goodwill The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 30, 2016 $ 309,616 Translation adjustments (865 ) Balance at March 31, 2017 $ 308,751 During the fiscal quarter ended December 30, 2016, we reorganized certain aspects of our internal business infrastructure primarily to integrate and align sales support more directly with our business units. In accordance with ASC Topic 350, we reviewed and reassigned our goodwill amongst our reporting units using a relative fair value allocation approach. Before doing so, we performed a “Step Zero” qualitative assessment during the quarter ended September 30, 2016 and determined that there was minimal risk of goodwill impairment in our pre-reorganization reporting units. Immediately after the reorganization, and related to our consolidated balance of goodwill of $307.1 million as of December 30, 2016, we initiated the "Step One" goodwill impairment assessment using a market approach and an income approach to value our reporting units. We completed this assessment as of March 31, 2017 and determined that there was no goodwill impairment. We did not incur any goodwill impairment losses in either the fiscal year-to-date period ended March 31, 2017 or April 1, 2016. Intangible Assets Our intangible assets are stated at their original cost less accumulated amortization, and principally consist of acquired technology, patents, trademarks, customer relationships and contracts. Intangible assets subject to amortization consist of the following (in thousands): March 31, 2017 September 30, 2016 Intangible Assets, Net Cost Accumulated Amortization Net Cost Accumulated Amortization Net Acquired patents and technology $ 298,556 $ (115,122 ) $ 183,434 $ 293,824 $ (101,711 ) $ 192,113 Customer relationships 56,803 (37,006 ) 19,797 56,821 (34,113 ) 22,708 Other intangibles 22,694 (22,202 ) 492 22,716 (22,195 ) 521 Total $ 378,053 $ (174,330 ) $ 203,723 $ 373,361 $ (158,019 ) $ 215,342 We purchase various patents and developed technologies that enable us to further develop our audio, imaging and potential product offerings. Patent Portfolio Acquisition. In the first quarter of fiscal 2016, we completed an asset purchase of a patent portfolio that fits within our existing patent licensing programs for consideration of $105.0 million . These assets are categorized within the "Acquired patents and technology" intangible asset class, and will be amortized over their weighted-average useful life of 9.0 years . With regard to our purchase of intangible assets during the periods presented, the following table summarizes the consideration paid, the weighted-average useful lives over which the acquired assets will be amortized using the greater of either the straight-line basis or a ratio-to-revenue method, and the classification of their amortized expense in our consolidated statements of operations: Fiscal Period Total Purchase Consideration (1) Weighted-Average Useful Life (in millions) (in years) Fiscal 2016 Q1 - Quarter ended January 1, 2016 $105.3 9.0 Q2 - Quarter ended April 1, 2016 None $105.3 9.0 Fiscal 2017 Q1 - Quarter ended December 30, 2016 None Q2 - Quarter ended March 31, 2017 $5.3 18.0 $5.3 18.0 (1) Amortization expense on the intangible assets from patent portfolio acquisitions is included within cost of revenue in our consolidated statements of operations. Amortization expense for our intangible assets is included in cost of licensing, cost of products, R&D and S&M expenses in our consolidated statements of operations. Amortization expense was $8.4 million and $8.2 million in the second quarter of fiscal 2017 and 2016 , respectively, and $16.8 million and $16.7 million in the fiscal year-to-date period ended March 31, 2017 and April 1, 2016 , respectively. As of March 31, 2017 , estimated amortization expense in future fiscal periods was as follows (in thousands): Fiscal Year Amortization Expense Remainder of 2017 $ 14,076 2018 25,592 2019 25,008 2020 24,545 2021 24,518 Thereafter 89,984 Total $ 203,723 |
Stockholders' Equity And Stock-
Stockholders' Equity And Stock-Based Compensation | 6 Months Ended |
Mar. 31, 2017 | |
Stockholders' Equity And Stock-Based Compensation [Abstract] | |
Stockholders' Equity And Stock-Based Compensation | 7 . Stockholders' Equity & Stock-Based Compensation We provide stock-based awards as a form of compensation for employees, officers and directors. We have issued stock-based awards in the form of stock options and RSUs under our equity incentive plans, as well as shares under our ESPP. Common Stock - Class A and Class B Our Board of Directors has authorized two classes of common stock, Class A and Class B. At March 31, 2017 , we had authorized 500,000,000 Class A shares and 500,000,000 Class B shares. At March 31, 2017 , we had 57,702,863 shares of Class A common stock and 44,073,597 shares of Class B common stock issued and outstanding. Holders of our Class A and Class B common stock have identical rights, except that holders of our Class A common stock are entitled to one vote per share and holders of our Class B common stock are entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in our amended and restated certificate of incorporation. Stock Incentive Plans 2005 Stock Plan. In January 2005, our stockholders approved our 2005 Stock Plan, which our Board of Directors adopted in November 2004. The 2005 Stock Plan became effective on February 16, 2005, the day prior to the completion of our initial public offering. Our 2005 Stock Plan, as amended and restated, provides for the ability to grant incentive stock options, non-qualified stock options, restricted stock, RSUs, stock appreciation rights, deferred stock units, performance units, performance bonus awards and performance shares. A total of 46.0 million shares of our Class A common stock is authorized for issuance under the 2005 Stock Plan. For awards granted prior to February 2011, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as two shares for every one share subject to the award, and if returned to the 2005 Stock Plan, such shares will be counted as two shares for every one share returned. For those awards granted from February 2011 onward, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as 1.6 shares for every one share subject to the award, and if returned to the 2005 Stock Plan, such shares will be counted as 1.6 for every one share returned. Stock Options. Stock options are granted at fair market value on the date of grant. Options granted to employees and officers prior to June 2008 generally vested over four years , with equal annual cliff-vesting and expire on the earlier of ten years after the date of grant or three months after termination of service. Options granted to employees and officers from June 2008 onward generally vest over four years, with 25% of the shares subject to the option becoming exercisable on the one-year anniversary of the date of grant and the balance of the shares vesting in equal monthly installments over the following 36 months . These options expire on the earlier of ten years after the date of grant or three months after termination of service. All options granted vest over the requisite service period and upon the exercise of stock options, we issue new shares of Class A common stock under the 2005 Stock Plan. Our 2005 Stock Plan also allows us to grant stock awards which vest based on the satisfaction of specific performance criteria. Performance-Based Stock Options (PSOs). In fiscal 2016, we began granting PSOs to our executive officers with shares of our Class A common stock underlying such options. The contractual term for the PSOs is seven years, with vesting contingent upon market-based performance conditions, representing the achievement of specified Dolby annualized TSR targets at the end of a three-year measurement period following the date of grant. If the minimum conditions are met, the PSOs earned will cliff vest on the third anniversary of the grant date, upon certification of achievement of the performance conditions by our Compensation Committee. Anywhere from 0% to 125% of the shares subject to a PSO may vest based on achievement of the performance conditions at the end of the three-year performance period. In valuing the PSOs which will be recognized as compensation cost, we used a Monte Carlo valuation model. Aside from the use of an expected term for the PSOs commensurate with their shorter contractual term, the nature of the valuation inputs used in the Monte Carlo valuation model were consistent with those used to value our non-performance based options granted under the 2005 Plan. Compensation cost is being amortized on a straight-line basis over the requisite service period. On December 15, 2016, we granted PSOs exercisable for an aggregate of up to 276,199 shares to our executive officers, all of which were outstanding as of March 31, 2017 . On December 15, 2015, we granted PSOs exercisable for an aggregate of up to 419,623 shares to our executive officers, of which 397,748 were outstanding as of March 31, 2017 . The following table summarizes information about all stock options issued under our 2005 Stock Plan: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value (1) (in thousands) (in years) (in thousands) Options outstanding at September 30, 2016 8,690 $ 35.98 Grants 1,959 46.05 Exercises (567 ) 33.06 Forfeitures and cancellations (69 ) 37.70 Options outstanding at March 31, 2017 10,013 38.10 7.1 $ 143,411 Options vested and expected to vest at March 31, 2017 9,268 37.84 7.0 135,212 Options exercisable at March 31, 2017 5,195 $ 35.55 6.0 87,726 (1) Aggregate intrinsic value is based on the closing price of our Class A common stock on March 31, 2017 of $52.41 and excludes the impact of options that were not in-the-money. Restricted Stock Units. Beginning in fiscal 2008, we began granting RSUs to certain directors, officers and employees under our 2005 Stock Plan. Awards granted to employees and officers generally vest over four years, with equal annual cliff-vesting. Awards granted to directors prior to November 2010 generally vest over three years, with equal annual cliff-vesting. Awards granted after November 2010 and prior to fiscal 2014 to new directors vest over approximately two years, with 50% vesting per year, while awards granted from November 2010 onward to ongoing directors generally vest over approximately one year. Awards granted to new directors from fiscal 2014 onward vest on the earlier of the first anniversary of the award’s date of grant, or the day immediately preceding the date of the next annual meeting of stockholders that occurs after the award’s date of grant. Our 2005 Stock Plan also allows us to grant RSUs that vest based on the satisfaction of specific performance criteria, although no such awards had been granted as of March 31, 2017 . At each vesting date, the holder of the award is issued shares of our Class A common stock. Compensation expense from these awards is equal to the fair market value of our Class A common stock on the date of grant and is recognized on a straight-line basis over the requisite service period. The following table summarizes information about RSUs issued under our 2005 Stock Plan: Shares Weighted-Average Grant Date Fair Value (in thousands) Non-vested at September 30, 2016 2,872 $ 40.16 Granted 1,091 46.15 Vested (1,000 ) 36.24 Forfeitures (63 ) 39.18 Non-vested at March 31, 2017 2,900 $ 43.79 Employee Stock Purchase Plan . Our plan allows eligible employees to have up to 10 percent of their eligible compensation withheld and used to purchase Class A common stock, subject to a maximum of $25,000 worth of stock purchased in a calendar year or no more than 1,000 shares in an offering period, whichever is less. An offering period consists of successive six -month purchase periods, with a look back feature to our stock price at the commencement of a one -year offering period. The plan provides for a discount equal to 15 percent of the lower of the closing price of our Class A common stock on the New York Stock Exchange on the first and last day of the offering periods. The plan also includes an automatic reset feature that provides for an offering period to be reset and recommenced to a new lower-priced offering if the offering price of a new offering period is less than that of the immediately preceding offering period. Stock Option Valuation Assumptions We use the Black-Scholes option pricing model to determine the estimated fair value of employee stock options at the date of the grant. The Black-Scholes model includes inputs that require us to make certain estimates and assumptions regarding the expected term of the award, as well as the risk-free interest rate, and the volatility of our stock price over the expected term of the award. Expected Term. The expected term of an award represents the estimated period of time that options granted will remain outstanding, and is measured from the grant date to the date at which the option is either exercised or canceled. Our determination of the expected term involves an evaluation of historical terms and other factors such as the exercise and termination patterns of our employees who hold options to acquire our Class A common stock, and is based on certain assumptions made regarding the future exercise and termination behavior. Risk-Free Interest Rate. The risk-free interest rate is based on the yield curve of United States Treasury instruments in effect on the date of grant. In determining an estimate for the risk-free interest rate, we use average interest rates based on these instruments’ constant maturities with a term that approximates and corresponds with the expected term of our awards. Expected Stock Price Volatility. The expected volatility represents the estimated volatility in the price of our Class A common stock over a time period that approximates the expected term of the awards, and is determined using a blended combination of historical and implied volatility. Historical volatility is representative of the historical trends in our stock price for periods preceding the measurement date for a period that is commensurate with the expected term. Implied volatility is based upon externally traded option contracts of our Class A common stock. Dividend Yield. The dividend yield is based on our anticipated dividend payout over the expected term of our option awards. Dividend declarations and the establishment of future record and payment dates are subject to the Board of Directors’ continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time. The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Expected term (in years) 5.13 5.24 5.13 5.24 Risk-free interest rate 1.9 % 1.5 % 2.1 % 1.7 % Expected stock price volatility 27.0 % 30.1 % 27.5 % 29.8 % Dividend yield 1.2 % 1.4 % 1.1 % 1.4 % Stock-Based Compensation Expense Stock-based compensation expense for equity awards granted to employees is determined by estimating their fair value on the date of grant, and recognizing that value as an expense on a straight-line basis over the requisite service period in which our employees earn the awards. Compensation expense related to these equity awards is recognized net of estimated forfeitures, which reduce the expense recorded in the consolidated statements of operations. The selection of applicable estimated forfeiture rates is based on an evaluation of trends in our historical forfeiture data with consideration for other potential driving factors. If in subsequent periods actual forfeitures significantly differ from our initial estimates, we will revise such estimates accordingly. The following two tables separately present stock-based compensation expense both by award type and classification in our consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Compensation Expense - By Type Stock options $ 4,575 $ 4,998 $ 9,378 $ 11,364 Restricted stock units 10,514 10,267 22,097 22,343 Employee stock purchase plan 894 821 1,723 1,759 Total stock-based compensation 15,983 16,086 33,198 35,466 Benefit from income taxes (4,635 ) (4,706 ) (9,663 ) (10,412 ) Total stock-based compensation, net of tax $ 11,348 $ 11,380 $ 23,535 $ 25,054 Expense - By Income Statement Line Item Classification Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Compensation Expense - By Classification Cost of products $ 223 $ 219 $ 481 $ 499 Cost of services 123 114 257 243 Research and development 4,506 4,268 9,436 9,375 Sales and marketing 6,509 6,441 13,376 14,151 General and administrative 4,622 5,044 9,648 11,198 Total stock-based compensation 15,983 16,086 33,198 35,466 Benefit from income taxes (4,635 ) (4,706 ) (9,663 ) (10,412 ) Total stock-based compensation, net of tax $ 11,348 $ 11,380 $ 23,535 $ 25,054 The tax benefit that we recognize from shares issued under our ESPP is excluded from the tables above. This benefit was as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Tax benefit - shares issued under ESPP $ 95 $ 28 $ 419 $ 123 Unrecognized Compensation Expense. At March 31, 2017 , total unrecorded compensation expense associated with employee stock options expected to vest was approximately $39.0 million , which is expected to be recognized over a weighted-average period of 2.5 years. At March 31, 2017 , total unrecorded compensation expense associated with RSUs expected to vest was approximately $90.5 million , which is expected to be recognized over a weighted-average period of 2.8 years. Common Stock Repurchase Program In November 2009, we announced a stock repurchase program ("program"), providing for the repurchase of up to $250.0 million of our Class A common stock. The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of March 31, 2017 (in thousands): Authorization Period Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Total $ 1,300,000 Stock repurchases under the program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans and other market conditions. The program does not have a specified expiration date, and can be limited, suspended or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be returned to the status of authorized but unissued shares of Class A common stock. As of March 31, 2017 , the remaining authorization to purchase additional shares is approximately $201.9 million . The following table provides information regarding share repurchase activity under the program during fiscal 2017 : Quarterly Repurchase Activity Shares Repurchased Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 30, 2016 531,465 $ 25,001 $ 47.02 Q2 - Quarter ended March 31, 2017 519,917 24,999 48.07 Total 1,051,382 $ 50,000 (1) Cost of share repurchases includes the price paid per share and applicable commissions. (2) Average price paid per share excludes commission costs. Dividend In October 2014, our Board of Directors initiated a recurring quarterly dividend program for our stockholders. The following table summarizes dividend payments to be made under the program in relation to fiscal 2017 : Fiscal Period Declaration Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Fiscal 2017 Q1 - Quarter ended December 30, 2016 January 25, 2017 February 6, 2017 February 15, 2017 $ 0.14 $14.3 million Q2 - Quarter ended March 31, 2017 April 26, 2017 May 8, 2017 May 16, 2017 $ 0.14 $14.3 million (1) (1) The amount of the dividend payment is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income | 6 Months Ended |
Mar. 31, 2017 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Income | 8 . Accumulated Other Comprehensive Income Other comprehensive income consists of two components: unrealized gains or losses on our AFS marketable investment securities and the gain or loss from foreign currency translation adjustments. Until realized and reported as a component of net income, these comprehensive income items accumulate and are included within accumulated other comprehensive income, a subsection within stockholders’ equity in our consolidated balance sheet. Unrealized gains and losses on our investment securities are reclassified from AOCI into earnings when realized upon sale, and are determined based on specific identification of securities sold. Gains and losses from the translation of assets and liabilities denominated in non-U.S. dollar functional currencies are included in AOCI. The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our consolidated statements of operations (in thousands): Fiscal Quarter Ended March 31, 2017 Fiscal Year-To-Date Ended March 31, 2017 Investment Securities Currency Translation Adjustments Total Investment Securities Currency Translation Adjustments Total Beginning Balance $ (1,277 ) $ (18,402 ) $ (19,679 ) $ 742 $ (10,939 ) $ (10,197 ) Other comprehensive income/(loss) before reclassifications: Unrealized gains/(losses) - investment securities 686 686 (1,474 ) (1,474 ) Foreign currency translation gains/(losses) (1) 4,989 4,989 (3,739 ) (3,739 ) Income tax effect - benefit/(expense) (99 ) (599 ) (698 ) 3 666 669 Net of tax 587 4,390 4,977 (1,471 ) (3,073 ) (4,544 ) Amounts reclassified from AOCI into earnings: Realized gains/(losses) - investment securities (1) (12 ) (12 ) 34 34 Income tax effect - benefit/(expense) (2) 6 6 (1 ) (1 ) Net of tax (6 ) — (6 ) 33 — 33 Net current-period other comprehensive (loss) 581 4,390 4,971 (1,438 ) (3,073 ) (4,511 ) Ending Balance $ (696 ) $ (14,012 ) $ (14,708 ) $ (696 ) $ (14,012 ) $ (14,708 ) Fiscal Quarter Ended April 1, 2016 Fiscal Year-To-Date Ended April 1, 2016 Investment Securities Currency Translation Adjustments Total Investment Securities Currency Translation Adjustments Total Beginning Balance $ (510 ) $ (12,413 ) $ (12,923 ) $ 350 $ (11,812 ) $ (11,462 ) Other comprehensive income/(loss) before reclassifications: Unrealized gains - investment securities 1,401 1,401 242 242 Foreign currency translation gains (1) 3,173 3,173 2,229 2,229 Income tax effect - benefit/(expense) (94 ) (155 ) (249 ) 105 188 293 Net of tax 1,307 3,018 4,325 347 2,417 2,764 Amounts reclassified from AOCI into earnings: Realized gains - investment securities (1) 347 347 478 478 Income tax effect - (expense) (2) (91 ) (91 ) (122 ) (122 ) Net of tax 256 — 256 356 — 356 Net current-period other comprehensive income 1,563 3,018 4,581 703 2,417 3,120 Ending Balance $ 1,053 $ (9,395 ) $ (8,342 ) $ 1,053 $ (9,395 ) $ (8,342 ) (1) Realized gains or losses from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/expense, net in our consolidated statements of operations. (2) The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations. |
Earnings Per Share
Earnings Per Share | 6 Months Ended |
Mar. 31, 2017 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | 9 . Earnings Per Share Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period. Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period presented, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS. Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and non-vested), vesting of outstanding RSUs, and shares issued under our employee stock purchase plan. The calculation of dilutive shares outstanding excludes out-of-the-money stock options (e.g., such options' exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 50,590 $ 67,398 $ 103,964 $ 98,299 Denominator: Weighted-average shares outstanding—basic 101,787 100,456 101,635 100,600 Potential common shares from options to purchase common stock 1,513 748 1,448 674 Potential common shares from restricted stock units 583 351 784 442 Weighted-average shares outstanding—diluted 103,883 101,555 103,867 101,716 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 0.50 $ 0.67 $ 1.02 $ 0.98 Diluted $ 0.49 $ 0.66 $ 1.00 $ 0.97 Antidilutive awards excluded from calculation: Stock options 1,819 7,124 1,222 6,349 Restricted stock units 2 733 8 184 |
Income Taxes
Income Taxes | 6 Months Ended |
Mar. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 10 . Income Taxes Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management's best assessment of estimated current and future taxes to be paid. We are subject to income taxes in both the United States and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax expense. Unrecognized Tax Benefit As of March 31, 2017 , the total amount of gross unrecognized tax benefits was $87.4 million , of which $75.3 million , if recognized, would reduce our effective tax rate. As of September 30, 2016 , the total amount of gross unrecognized tax benefits was $75.2 million , of which $62.1 million , if recognized, would reduce our effective tax rate. Our net liability for unrecognized tax benefits is classified within other non-current liabilities in our consolidated balance sheets. Withholding Taxes We recognize licensing revenue gross of withholding taxes, which our licensees remit directly to their local tax authorities, and for which we receive a partial foreign tax credit in our income tax provision. The foreign current tax includes this withholding tax expense while the appropriate foreign tax credit benefit is included in current federal and foreign taxes. Withholding taxes were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Withholding taxes $ 13,408 $ 12,406 $ 22,399 $ 22,188 Effective Tax Rate Each period, the combination of different factors can impact our effective tax rate. These factors include both recurring items such as tax rates and the relative amount of income earned in foreign jurisdictions, as well as discrete items such as changes to our uncertain tax positions, that may occur in, but are not necessarily consistent between periods. Our effective tax rate in the second quarter of fiscal 2017 was 23.4% , compared to 19.4% in the second quarter of fiscal 2016 . The increase in our effective tax rate reflects a decrease in discrete benefits from the settlement of prior years' state audit, partially offset by increased benefits from a relative change in foreign earned income. Our effective tax rate was 22.1% in the fiscal year-to-date period ended March 31, 2017 , compared to 20.1% in the fiscal year-to-date period ended April 1, 2016 . The increase in our effective tax rate reflects decreases in discrete benefits from the both R&D credits and settlement of prior years' state audit, partially offset by increased benefits from a relative change in foreign earned income. |
Commitments And Contingencies
Commitments And Contingencies | 6 Months Ended |
Mar. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments And Contingencies | 12 . Commitments & Contingencies In the ordinary course of business, we enter into contractual agreements with third parties that include non-cancelable payment obligations, for which we are liable in future periods. These arrangements can include terms binding us to minimum payments and/or penalties if we terminate the agreement for any reason other than an event of default as described by the agreement. The following table presents a summary of our contractual obligations and commitments as of March 31, 2017 (in thousands): Payments Due By Fiscal Period Remainder Of Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ — $ 7,715 $ 7,811 $ 7,909 $ 8,008 $ 94,972 $ 126,415 Donation commitments — 6,300 322 322 122 1,013 8,079 Operating leases 8,030 14,411 11,865 11,108 9,809 33,520 88,743 Purchase obligations 7,579 8,300 24,289 21,010 — — 61,178 Total $ 15,609 $ 36,726 $ 44,287 $ 40,349 $ 17,939 $ 129,505 $ 284,415 Naming Rights. We are party to an agreement for naming rights and related benefits with respect to the Dolby Theatre in Hollywood, California, the location of the Academy Awards®. The term of the agreement is 20 years, over which we will make payments on a semi-annual basis until fiscal 2032. Our payment obligations are conditioned in part on the Academy Awards® being held and broadcast from the Dolby Theatre. Donation Commitments. Donation commitments primarily relate to a non-cancelable obligation entered into during fiscal 2014 to install and donate imaging and audio products to the Museum of the Academy of Motion Picture Arts and Sciences in Los Angeles, California, and to provide maintenance services for fifteen years from its expected opening date in fiscal 2018, in exchange for various marketing, branding and publicity benefits. Operating Leases . Operating lease payments represent our commitments for future minimum rent made under non-cancelable leases for office space, including those payable to our principal stockholder and portions attributable to the controlling interests in our wholly owned subsidiaries. Purchase Obligations. Purchase obligations primarily consist of our commitments made under agreements to purchase goods and services related to Dolby Cinema and for purposes that include IT and telecommunications, marketing and professional services, and manufacturing and other R&D activities. Indemnification Clauses. On a limited basis, our contractual agreements contain a clause under which we agree to provide indemnification to the counterparty, most commonly to licensees in connection with licensing arrangements that include our IP property. Additionally, and although not a contractual requirement, we have at times elected to defend our licensees from third party IP infringement claims. Since the terms and conditions of our contractual indemnification clauses do not explicitly specify our obligations, we are unable to reasonably estimate the maximum potential exposure for which we could be liable. Furthermore, we have not historically made any payments in connection with any such obligation and believe there to be a remote likelihood that any potential exposure in future periods would be of a material amount. As a result, no amounts have been accrued in our consolidated financial statements with respect to the contingent aspect of these indemnities. |
Legal Proceedings
Legal Proceedings | 6 Months Ended |
Mar. 31, 2017 | |
Loss Contingency, Information about Litigation Matters [Abstract] | |
Legal Proceedings | 11 . Legal Matters We are involved in various legal proceedings that occasionally arise in the normal course of business. These can include claims of alleged infringement of IP rights, commercial, employment and other matters. In our opinion, resolution of these proceedings is not expected to have a material adverse impact on our operating results or financial condition. Given the unpredictable nature of legal proceedings, it is possible that an unfavorable resolution of one or more such proceedings could materially affect our future operating results or financial condition in a particular period, including as a result of required changes to our licensing terms, monetary penalties and other potential consequences. However, based on the information known by us as of the date of this filing and the rules and regulations applicable to the preparation of our consolidated financial statements, any such amounts are either immaterial, or it is not possible to provide an estimated amount of any such potential losses. |
Summary Of Significant Accoun21
Summary Of Significant Accounting Policies (Policy) | 6 Months Ended |
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Principles Of Consolidation | Principles of Consolidation The unaudited interim condensed consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder has a controlling interest. We report these controlling interests as a separate line in our consolidated statements of operations as net income attributable to controlling interest and in our consolidated balance sheets as a controlling interest. We eliminate all intercompany accounts and transactions upon consolidation. |
Operating Segments | Operating Segments We operate as a single reportable segment. During the fiscal quarter ended December 30, 2016, we reorganized certain aspects of our internal business infrastructure primarily to integrate and align sales support more directly with our business units. Following the reorganization, we reassessed our business units and concluded that the composition of our reportable segments remains unchanged and that we continue to operate as a single reportable segment. This reflects the fact that our CODM, our Chief Executive Officer, continues to evaluate our financial information and resources, and continues to assess the performance of these resources, on a consolidated basis. All required financial segment information is therefore included in our unaudited interim condensed consolidated financial statements. |
Use of Estimates | Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our unaudited interim condensed consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated selling prices for elements sold in ME revenue arrangements; valuation allowances for accounts receivable; carrying values of inventories and certain property, plant, and equipment, goodwill and intangible assets; fair values of investments; accrued liabilities including liabilities for unrecognized tax benefits, deferred income tax assets and liabilities and stock-based compensation. Actual results could differ from our estimates. |
Fiscal Year | Fiscal Year Our fiscal year is a 52 or 53 week period ending on the last Friday in September. The fiscal periods presented herein include the 13 week period ended March 31, 2017 and the 14 week period ended April 1, 2016 . Our fiscal year ended September 30, 2016 (fiscal 2016 ) consisted of 53 weeks while our fiscal year ending September 29, 2017 (fiscal 2017 ) will consist of 52 weeks. |
Composition Of Certain Financ22
Composition Of Certain Financial Statement Captions (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Composition Of Certain Financial Statement Captions [Abstract] | |
Schedule Of Accounts Receivable | Accounts Receivable March 31, September 30, Trade accounts receivable $ 78,755 $ 66,229 Accounts receivable from patent administration program customers 12,719 11,829 Accounts receivable, gross 91,474 78,058 Less: allowance for doubtful accounts (3,258 ) (2,370 ) Total $ 88,216 $ 75,688 |
Schedule Of Inventories | Inventories March 31, September 30, Raw materials $ 3,934 $ 3,526 Work in process 3,236 4,020 Finished goods 10,527 8,808 Total $ 17,697 $ 16,354 |
Schedule Of Prepaid Expenses And Other Current Assets | Prepaid Expenses And Other Current Assets March 31, September 30, Prepaid expenses $ 17,532 $ 13,440 Other current assets 10,510 11,578 Income tax receivable 4,459 1,284 Total $ 32,501 $ 26,302 |
Schedule Of Accrued Liabilities | Accrued Liabilities March 31, September 30, Accrued royalties $ 2,144 $ 1,939 Amounts payable to patent administration program partners 49,953 34,472 Accrued compensation and benefits 59,458 71,261 Accrued professional fees 7,896 6,528 Other accrued liabilities 59,578 54,855 Total $ 179,029 $ 169,055 |
Schedule Of Other Non-Current Liabilities | Other Non-Current Liabilities March 31, September 30, Supplemental retirement plan obligations $ 2,694 $ 2,540 Non-current tax liabilities 80,925 68,254 Other liabilities 12,313 12,128 Total $ 95,932 $ 82,922 |
Investments & Fair Value Meas23
Investments & Fair Value Measurements (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] | |
Schedule Of Financial Assets and Liabilities Carried At Fair Value | March 31, 2017 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 522,850 $ 522,850 Cash equivalents: Money market funds 9,498 — — 9,498 9,498 Corporate bonds 160 — — 160 160 Cash and cash equivalents 532,508 — — 532,508 9,498 160 — Short-term investments: Certificate of deposit (1) 28,318 19 (6 ) 28,331 28,331 U.S. agency securities 2,715 — (3 ) 2,712 2,712 Commercial paper 15,353 5 (1 ) 15,357 15,357 Corporate bonds 127,350 48 (109 ) 127,289 127,289 Municipal debt securities 21,312 2 (6 ) 21,308 21,308 Short-term investments 195,048 74 (125 ) 194,997 2,712 192,285 — Long-term investments: Certificate of deposit (1) 6,230 — (2 ) 6,228 6,228 U.S. agency securities 24,809 — (217 ) 24,592 24,592 Government bonds 22,994 4 (197 ) 22,801 22,801 Corporate bonds 228,406 322 (795 ) 227,933 227,933 Municipal debt securities 41,592 52 (57 ) 41,587 41,587 Other long-term investments (2) 3,282 377 — 3,659 377 Long-term investments 327,313 755 (1,268 ) 326,800 47,770 275,748 — Total cash, cash equivalents, and investments $ 1,054,869 $ 829 $ (1,393 ) $ 1,054,305 $ 59,980 $ 468,193 $ — Investments held in supplemental retirement plan: Assets 2,792 2,792 2,792 Included in prepaid expenses and other current assets & other non-current assets Liabilities 2,792 2,792 2,792 Included in accrued liabilities & other non-current liabilities (1) Certificates of deposit include marketable securities, while those with a maturity in excess of one year as of March 31, 2017 are classified within long-term investments. (2) Other long-term investments as of March 31, 2017 include a marketable equity security of $0.4 million , and other investments that are not carried at fair value including an equity method investment of $0.8 million and two cost method investments of $2.0 million and $0.5 million . September 30, 2016 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 501,863 $ 501,863 Cash equivalents: Commercial paper 1,099 — — 1,099 1,099 Corporate bonds 2,240 — — 2,240 2,240 Money market funds 10,910 — — 10,910 10,910 Cash and cash equivalents 516,112 — — 516,112 10,910 3,339 — Short-term investments: Certificate of deposit (1) 13,912 6 — 13,918 13,918 Commercial paper 19,629 1 (10 ) 19,620 19,620 Corporate bonds 63,762 24 (14 ) 63,772 63,772 Municipal debt securities 24,334 — (15 ) 24,319 24,319 Short-term investments 121,637 31 (39 ) 121,629 — 121,629 — Long-term investments: Certificate of deposit (1) 4,500 10 — 4,510 4,510 U.S. agency securities 27,536 24 (26 ) 27,534 27,534 Government bonds 31,971 77 (12 ) 32,036 32,036 Corporate bonds 295,921 715 (266 ) 296,370 296,370 Municipal debt securities 30,090 28 (32 ) 30,086 30,086 Other long-term investments (2) 3,002 366 — 3,368 366 Long-term investments 393,020 1,220 (336 ) 393,904 59,936 330,966 — Total cash, cash equivalents, and investments $ 1,030,769 $ 1,251 $ (375 ) $ 1,031,645 $ 70,846 $ 455,934 $ — Investments held in supplemental retirement plan: Assets 2,638 2,638 2,638 Included in prepaid expenses and other current assets & other non-current assets Liabilities 2,638 2,638 2,638 Included in accrued liabilities & other non-current liabilities Our cash and investment portfolio consists of the following (in thousands): March 31, 2017 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 522,850 $ 522,850 Cash equivalents: Money market funds 9,498 — — 9,498 9,498 Corporate bonds 160 — — 160 160 Cash and cash equivalents 532,508 — — 532,508 9,498 160 — Short-term investments: Certificate of deposit (1) 28,318 19 (6 ) 28,331 28,331 U.S. agency securities 2,715 — (3 ) 2,712 2,712 Commercial paper 15,353 5 (1 ) 15,357 15,357 Corporate bonds 127,350 48 (109 ) 127,289 127,289 Municipal debt securities 21,312 2 (6 ) 21,308 21,308 Short-term investments 195,048 74 (125 ) 194,997 2,712 192,285 — Long-term investments: Certificate of deposit (1) 6,230 — (2 ) 6,228 6,228 U.S. agency securities 24,809 — (217 ) 24,592 24,592 Government bonds 22,994 4 (197 ) 22,801 22,801 Corporate bonds 228,406 322 (795 ) 227,933 227,933 Municipal debt securities 41,592 52 (57 ) 41,587 41,587 Other long-term investments (2) 3,282 377 — 3,659 377 Long-term investments 327,313 755 (1,268 ) 326,800 47,770 275,748 — Total cash, cash equivalents, and investments $ 1,054,869 $ 829 $ (1,393 ) $ 1,054,305 $ 59,980 $ 468,193 $ — Investments held in supplemental retirement plan: Assets 2,792 2,792 2,792 Included in prepaid expenses and other current assets & other non-current assets Liabilities 2,792 2,792 2,792 Included in accrued liabilities & other non-current liabilities (1) Certificates of deposit include marketable securities, while those with a maturity in excess of one year as of March 31, 2017 are classified within long-term investments. (2) Other long-term investments as of March 31, 2017 include a marketable equity security of $0.4 million , and other investments that are not carried at fair value including an equity method investment of $0.8 million and two cost method investments of $2.0 million and $0.5 million . September 30, 2016 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 501,863 $ 501,863 Cash equivalents: Commercial paper 1,099 — — 1,099 1,099 Corporate bonds 2,240 — — 2,240 2,240 Money market funds 10,910 — — 10,910 10,910 Cash and cash equivalents 516,112 — — 516,112 10,910 3,339 — Short-term investments: Certificate of deposit (1) 13,912 6 — 13,918 13,918 Commercial paper 19,629 1 (10 ) 19,620 19,620 Corporate bonds 63,762 24 (14 ) 63,772 63,772 Municipal debt securities 24,334 — (15 ) 24,319 24,319 Short-term investments 121,637 31 (39 ) 121,629 — 121,629 — Long-term investments: Certificate of deposit (1) 4,500 10 — 4,510 4,510 U.S. agency securities 27,536 24 (26 ) 27,534 27,534 Government bonds 31,971 77 (12 ) 32,036 32,036 Corporate bonds 295,921 715 (266 ) 296,370 296,370 Municipal debt securities 30,090 28 (32 ) 30,086 30,086 Other long-term investments (2) 3,002 366 — 3,368 366 Long-term investments 393,020 1,220 (336 ) 393,904 59,936 330,966 — Total cash, cash equivalents, and investments $ 1,030,769 $ 1,251 $ (375 ) $ 1,031,645 $ 70,846 $ 455,934 $ — Investments held in supplemental retirement plan: Assets 2,638 2,638 2,638 Included in prepaid expenses and other current assets & other non-current assets Liabilities 2,638 2,638 2,638 Included in accrued liabilities & other non-current liabilities (1) Certificates of deposit include marketable securities, while those with a maturity in excess of one year as of September 30, 2016 are classified within long-term investments. (2) Other long-term investments as of September 30, 2016 include a marketable equity security of $0.4 million , and other investments that are not carried at fair value including an equity method investment of $0.5 million and two cost method investments of $2.0 million and $0.5 million . |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for twelve months or greater as of March 31, 2017 and September 30, 2016 (in thousands): March 31, 2017 September 30, 2016 Less Than 12 Months 12 Months Or Greater Less Than 12 Months 12 Months Or Greater Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Certificate of deposit $ 14,412 $ (8 ) $ — $ — $ — $ — $ — $ — U.S. agency securities 27,304 (220 ) — — 22,988 (38 ) — — Government bonds 19,799 (197 ) — — — — — — Commercial paper 4,951 (1 ) — — 11,479 (10 ) — — Corporate bonds 212,903 (904 ) — — 153,491 (280 ) 1,000 — Municipal debt securities 33,902 (62 ) 1,250 (1 ) 35,625 (42 ) 4,615 (5 ) Total $ 313,271 $ (1,392 ) $ 1,250 $ (1 ) $ 223,583 $ (370 ) $ 5,615 $ (5 ) |
Available-for-sale Securities | The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of March 31, 2017 and September 30, 2016 , which are recorded within cash equivalents and both short and long-term investments in our consolidated balance sheets (in thousands): March 31, 2017 September 30, 2016 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 204,708 $ 204,655 $ 135,886 $ 135,884 Due in 1 to 2 years 219,732 219,571 225,679 225,953 Due in 2 to 3 years 104,297 103,570 164,339 164,583 Total $ 528,737 $ 527,796 $ 525,904 $ 526,420 |
Property, Plant and Equipment (
Property, Plant and Equipment (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | Property, plant and equipment are recorded at cost, with depreciation expense included in cost of licensing, cost of products, cost of services, R&D, S&M and G&A expenses in our consolidated statements of operations. PP&E consist of the following (in thousands): March 31, September 30, Land $ 43,270 $ 43,325 Buildings and building improvements 276,916 251,700 Leasehold improvements 61,626 60,480 Machinery and equipment 94,917 88,943 Computer equipment and software 162,883 154,291 Furniture and fixtures 27,735 26,900 Equipment provided under operating leases 73,912 35,968 Construction-in-progress 6,520 32,576 Property, plant and equipment, gross 747,779 694,183 Less: accumulated depreciation (276,684 ) (250,527 ) Property, plant and equipment, net $ 471,095 $ 443,656 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 30, 2016 $ 309,616 Translation adjustments (865 ) Balance at March 31, 2017 $ 308,751 |
Schedule of Finite-Lived Intangible Assets | Intangible assets subject to amortization consist of the following (in thousands): March 31, 2017 September 30, 2016 Intangible Assets, Net Cost Accumulated Amortization Net Cost Accumulated Amortization Net Acquired patents and technology $ 298,556 $ (115,122 ) $ 183,434 $ 293,824 $ (101,711 ) $ 192,113 Customer relationships 56,803 (37,006 ) 19,797 56,821 (34,113 ) 22,708 Other intangibles 22,694 (22,202 ) 492 22,716 (22,195 ) 521 Total $ 378,053 $ (174,330 ) $ 203,723 $ 373,361 $ (158,019 ) $ 215,342 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | As of March 31, 2017 , estimated amortization expense in future fiscal periods was as follows (in thousands): Fiscal Year Amortization Expense Remainder of 2017 $ 14,076 2018 25,592 2019 25,008 2020 24,545 2021 24,518 Thereafter 89,984 Total $ 203,723 |
Stockholders' Equity And Stoc26
Stockholders' Equity And Stock-Based Compensation (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Stockholders' Equity And Stock-Based Compensation [Abstract] | |
Summary Of Stock Options Issued To Officers, Directors, And Employees Under 2000 Stock Incentive Plan And 2005 Stock Plan | The following table summarizes information about all stock options issued under our 2005 Stock Plan: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value (1) (in thousands) (in years) (in thousands) Options outstanding at September 30, 2016 8,690 $ 35.98 Grants 1,959 46.05 Exercises (567 ) 33.06 Forfeitures and cancellations (69 ) 37.70 Options outstanding at March 31, 2017 10,013 38.10 7.1 $ 143,411 Options vested and expected to vest at March 31, 2017 9,268 37.84 7.0 135,212 Options exercisable at March 31, 2017 5,195 $ 35.55 6.0 87,726 (1) Aggregate intrinsic value is based on the closing price of our Class A common stock on March 31, 2017 of $52.41 and excludes the impact of options that were not in-the-money. |
Summary Of Restricted Stock Units Issued To Officers, Directors And Employees Under 2005 Stock Incentive Plan | The following table summarizes information about RSUs issued under our 2005 Stock Plan: Shares Weighted-Average Grant Date Fair Value (in thousands) Non-vested at September 30, 2016 2,872 $ 40.16 Granted 1,091 46.15 Vested (1,000 ) 36.24 Forfeitures (63 ) 39.18 Non-vested at March 31, 2017 2,900 $ 43.79 |
Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions | The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Expected term (in years) 5.13 5.24 5.13 5.24 Risk-free interest rate 1.9 % 1.5 % 2.1 % 1.7 % Expected stock price volatility 27.0 % 30.1 % 27.5 % 29.8 % Dividend yield 1.2 % 1.4 % 1.1 % 1.4 % |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | The following two tables separately present stock-based compensation expense both by award type and classification in our consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Compensation Expense - By Type Stock options $ 4,575 $ 4,998 $ 9,378 $ 11,364 Restricted stock units 10,514 10,267 22,097 22,343 Employee stock purchase plan 894 821 1,723 1,759 Total stock-based compensation 15,983 16,086 33,198 35,466 Benefit from income taxes (4,635 ) (4,706 ) (9,663 ) (10,412 ) Total stock-based compensation, net of tax $ 11,348 $ 11,380 $ 23,535 $ 25,054 Expense - By Income Statement Line Item Classification Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Compensation Expense - By Classification Cost of products $ 223 $ 219 $ 481 $ 499 Cost of services 123 114 257 243 Research and development 4,506 4,268 9,436 9,375 Sales and marketing 6,509 6,441 13,376 14,151 General and administrative 4,622 5,044 9,648 11,198 Total stock-based compensation 15,983 16,086 33,198 35,466 Benefit from income taxes (4,635 ) (4,706 ) (9,663 ) (10,412 ) Total stock-based compensation, net of tax $ 11,348 $ 11,380 $ 23,535 $ 25,054 |
Schedule of Tax Benefit from Exercise of Options | This benefit was as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Tax benefit - shares issued under ESPP $ 95 $ 28 $ 419 $ 123 |
Schedule of Stock Repurchase Authorizations | The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of March 31, 2017 (in thousands): Authorization Period Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Total $ 1,300,000 |
Schedule of Stock Repurchase Activity | The following table provides information regarding share repurchase activity under the program during fiscal 2017 : Quarterly Repurchase Activity Shares Repurchased Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 30, 2016 531,465 $ 25,001 $ 47.02 Q2 - Quarter ended March 31, 2017 519,917 24,999 48.07 Total 1,051,382 $ 50,000 (1) Cost of share repurchases includes the price paid per share and applicable commissions. (2) Average price paid per share excludes commission costs. |
Dividends Declared | In October 2014, our Board of Directors initiated a recurring quarterly dividend program for our stockholders. The following table summarizes dividend payments to be made under the program in relation to fiscal 2017 : Fiscal Period Declaration Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Fiscal 2017 Q1 - Quarter ended December 30, 2016 January 25, 2017 February 6, 2017 February 15, 2017 $ 0.14 $14.3 million Q2 - Quarter ended March 31, 2017 April 26, 2017 May 8, 2017 May 16, 2017 $ 0.14 $14.3 million (1) (1) The amount of the dividend payment is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date. |
Accumulated Other Comprehensi27
Accumulated Other Comprehensive Income (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Equity [Abstract] | |
Schedule of Accumulated Other Comprehensive Income (Loss) | Other comprehensive income consists of two components: unrealized gains or losses on our AFS marketable investment securities and the gain or loss from foreign currency translation adjustments. Until realized and reported as a component of net income, these comprehensive income items accumulate and are included within accumulated other comprehensive income, a subsection within stockholders’ equity in our consolidated balance sheet. Unrealized gains and losses on our investment securities are reclassified from AOCI into earnings when realized upon sale, and are determined based on specific identificati |
Per Share Data (Tables)
Per Share Data (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 50,590 $ 67,398 $ 103,964 $ 98,299 Denominator: Weighted-average shares outstanding—basic 101,787 100,456 101,635 100,600 Potential common shares from options to purchase common stock 1,513 748 1,448 674 Potential common shares from restricted stock units 583 351 784 442 Weighted-average shares outstanding—diluted 103,883 101,555 103,867 101,716 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 0.50 $ 0.67 $ 1.02 $ 0.98 Diluted $ 0.49 $ 0.66 $ 1.00 $ 0.97 Antidilutive awards excluded from calculation: Stock options 1,819 7,124 1,222 6,349 Restricted stock units 2 733 8 184 |
Income Taxes (Tables)
Income Taxes (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Schedule of Withholding Taxes | Withholding taxes were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended March 31, April 1, March 31, April 1, Withholding taxes $ 13,408 $ 12,406 $ 22,399 $ 22,188 |
Commitments And Contingencies (
Commitments And Contingencies (Tables) | 6 Months Ended |
Mar. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule Of Contractual Obligations And Commitments | The following table presents a summary of our contractual obligations and commitments as of March 31, 2017 (in thousands): Payments Due By Fiscal Period Remainder Of Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ — $ 7,715 $ 7,811 $ 7,909 $ 8,008 $ 94,972 $ 126,415 Donation commitments — 6,300 322 322 122 1,013 8,079 Operating leases 8,030 14,411 11,865 11,108 9,809 33,520 88,743 Purchase obligations 7,579 8,300 24,289 21,010 — — 61,178 Total $ 15,609 $ 36,726 $ 44,287 $ 40,349 $ 17,939 $ 129,505 $ 284,415 |
Basis Of Presentation (Details)
Basis Of Presentation (Details) - segment | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Dec. 30, 2016 | Jan. 01, 2016 | Mar. 31, 2017 | Sep. 29, 2017 | Sep. 30, 2016 | |
Significant Accounting Policies [Line Items] | |||||
Number of weeks in fiscal year | 13 years | 14 years | 53 years | ||
Number of Operating Segments | 1 | ||||
Scenario, Forecast [Member] | |||||
Significant Accounting Policies [Line Items] | |||||
Number of weeks in fiscal year | 52 years |
Composition Of Certain Financ32
Composition Of Certain Financial Statement Captions (Schedule Of Accounts Receivable) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Composition Of Certain Financial Statement Captions [Abstract] | ||
Trade accounts receivable | $ 78,755 | $ 66,229 |
Accounts receivable related to patent administration program | 12,719 | 11,829 |
Accounts receivable, gross | 91,474 | 78,058 |
Less: allowance for doubtful accounts | (3,258) | (2,370) |
Accounts receivable, net | $ 88,216 | $ 75,688 |
Composition Of Certain Financ33
Composition Of Certain Financial Statement Captions (Schedule Of Inventories) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Composition Of Certain Financial Statement Captions [Abstract] | ||
Raw materials | $ 3,934 | $ 3,526 |
Work in process | 3,236 | 4,020 |
Finished goods | 10,527 | 8,808 |
Inventories | $ 17,697 | $ 16,354 |
Composition Of Certain Financ34
Composition Of Certain Financial Statement Captions (Narrative) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Composition Of Certain Financial Statement Captions [Line Items] | ||
Raw materials | $ 3,934 | $ 3,526 |
Capital expenditures incurred, but not yet paid | 21,200 | 17,100 |
Other Noncurrent Assets [Member] | ||
Composition Of Certain Financial Statement Captions [Line Items] | ||
Raw materials | $ 2,000 | $ 1,600 |
Composition Of Certain Financ35
Composition Of Certain Financial Statement Captions (Schedule Of Prepaid Expenses And Other Current Assets) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Composition Of Certain Financial Statement Captions [Abstract] | ||
Prepaid assets | $ 17,532 | $ 13,440 |
Other current assets | 10,510 | 11,578 |
Income tax receivable | 4,459 | 1,284 |
Prepaid expenses and other current assets | $ 32,501 | $ 26,302 |
Composition Of Certain Financ36
Composition Of Certain Financial Statement Captions (Schedule Of Accrued Liabilities) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Composition Of Certain Financial Statement Captions [Abstract] | ||
Accrued royalties | $ 2,144 | $ 1,939 |
Amounts payable to patent administration program partners | 49,953 | 34,472 |
Accrued compensation and benefits | 59,458 | 71,261 |
Accrued professional fees | 7,896 | 6,528 |
Other accrued liabilities | 59,578 | 54,855 |
Total | 179,029 | 169,055 |
Capital expenditures incurred, but not yet paid | $ 21,200 | $ 17,100 |
Composition Of Certain Financ37
Composition Of Certain Financial Statement Captions (Schedule Of Other Non-Current Liabilities) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Composition Of Certain Financial Statement Captions [Abstract] | ||
Supplemental retirement plan obligations | $ 2,694 | $ 2,540 |
Non-current tax liabilities | 80,925 | 68,254 |
Other liabilities | 12,313 | 12,128 |
Other non-current liabilities | $ 95,932 | $ 82,922 |
Investments & Fair Value Meas38
Investments & Fair Value Measurements (Schedule Of Financial Assets and Liabilities Carried At Fair Value) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | $ 532,508 | $ 516,112 |
Available-for-sale Debt Securities, Amortized Cost Basis | 528,737 | 525,904 |
Available-for-sale Securities, Debt Securities | 527,796 | 526,420 |
Investment Owned, Unrecognized Unrealized Depreciation | (1,393) | (375) |
Cash Cash Equivalents And Investments Total | 1,054,305 | 1,031,645 |
Financial assets carried at fair value | 516,112 | |
Restricted Cash and Cash Equivalents | 5,752 | 3,645 |
Long-term investments | 326,800 | 393,904 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | 313,271 | 223,583 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (1,392) | (370) |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 1,250 | 5,615 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (1) | (5) |
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis | 204,708 | 135,886 |
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value | 204,655 | 135,884 |
Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost | 219,732 | 225,679 |
Available For Sale Securities Debt Maturities After One Through Two Years Fair Value | 219,571 | 225,953 |
Available For Sale Securities Debt Maturities After Two Through Three Years Amortized Cost | 104,297 | 164,339 |
Available For Sale Securities Debt Maturities After Two Through Three Years Fair Value | 103,570 | 164,583 |
Investment Owned, at Cost | 1,054,869 | 1,030,769 |
Investment Owned, Unrecognized Unrealized Appreciation | 829 | 1,251 |
Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 9,498 | 10,910 |
Financial assets carried at fair value | 59,980 | 70,846 |
Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 160 | 3,339 |
Financial assets carried at fair value | 468,193 | 455,934 |
Cash [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 522,850 | 501,863 |
Money Market Funds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 9,498 | 10,910 |
Money Market Funds [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 9,498 | 10,910 |
Certificates of Deposit [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | 14,412 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (8) | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 0 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 0 |
U.S. Agency Securities [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | 27,304 | 22,988 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (220) | (38) |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 0 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 0 |
Government Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | 19,799 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (197) | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 0 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 0 |
Commercial Paper [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | 4,951 | 11,479 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (1) | (10) |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 0 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 0 |
Corporate Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 160 | 2,240 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | 212,903 | 153,491 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (904) | (280) |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 0 | 1,000 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 0 |
Corporate Bonds [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 2,240 | |
Corporate Bonds [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 160 | |
Municipal Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | 33,902 | 35,625 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (62) | (42) |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 1,250 | 4,615 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (1) | (5) |
Other Long-term Investments [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 800 | 500 |
Cost Method Investment, Fair Value Measurement Adjustment | 400 | 400 |
Investments Held In Supplemental Retirement Plan [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Financial assets carried at fair value | 2,792 | 2,638 |
Financial liabilities carried at fair value | 2,792 | 2,638 |
Cost Method Investment 1 [Member] | Other Long-term Investments [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Long-term investments | 2,000 | 2,000 |
Cost Method Investment 2 [Member] | Other Long-term Investments [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Long-term investments | 500 | 500 |
Short-term Investments [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Debt Securities, Amortized Cost Basis | 195,048 | 121,637 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 74 | 31 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | (125) | (39) |
Available-for-sale Securities, Debt Securities | 194,997 | 121,629 |
Short-term Investments [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Fair Value Disclosure | 2,712 | 0 |
Short-term Investments [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Fair Value Disclosure | 192,285 | 121,629 |
Short-term Investments [Member] | Certificates of Deposit [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 28,318 | 13,912 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 19 | 6 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | (6) | 0 |
Available-for-sale Securities | 28,331 | 13,918 |
Short-term Investments [Member] | Certificates of Deposit [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Fair Value Disclosure | 28,331 | 13,918 |
Short-term Investments [Member] | U.S. Agency Securities [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Debt Securities, Amortized Cost Basis | 2,715 | |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 0 | |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | (3) | |
Available-for-sale Securities, Debt Securities | 2,712 | |
Short-term Investments [Member] | U.S. Agency Securities [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Fair Value Disclosure | 2,712 | |
Short-term Investments [Member] | Commercial Paper [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 1,099 | |
Available-for-sale Debt Securities, Amortized Cost Basis | 15,353 | 19,629 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 5 | 1 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | (1) | (10) |
Available-for-sale Securities, Debt Securities | 15,357 | 19,620 |
Short-term Investments [Member] | Commercial Paper [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and Cash Equivalents, Fair Value Disclosure | 1,099 | |
Investments, Fair Value Disclosure | 15,357 | 19,620 |
Short-term Investments [Member] | Corporate Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Debt Securities, Amortized Cost Basis | 127,350 | 63,762 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 48 | 24 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | (109) | (14) |
Available-for-sale Securities, Debt Securities | 127,289 | 63,772 |
Short-term Investments [Member] | Corporate Bonds [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Fair Value Disclosure | 127,289 | 63,772 |
Short-term Investments [Member] | Municipal Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Debt Securities, Amortized Cost Basis | 21,312 | 24,334 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 2 | 0 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | (6) | (15) |
Available-for-sale Securities, Debt Securities | 21,308 | 24,319 |
Short-term Investments [Member] | Municipal Bonds [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Fair Value Disclosure | 21,308 | 24,319 |
Long-term Investments [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 327,313 | 393,020 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 755 | 1,220 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | (1,268) | (336) |
Available-for-sale Securities | 326,800 | 393,904 |
Long-term Investments [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 47,770 | 59,936 |
Long-term Investments [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 275,748 | 330,966 |
Long-term Investments [Member] | Certificates of Deposit [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 6,230 | 4,500 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 0 | 10 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | (2) | 0 |
Available-for-sale Securities | 6,228 | 4,510 |
Long-term Investments [Member] | Certificates of Deposit [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 6,228 | 4,510 |
Long-term Investments [Member] | U.S. Agency Securities [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 24,809 | 27,536 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 0 | 24 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | (217) | (26) |
Available-for-sale Securities | 24,592 | 27,534 |
Long-term Investments [Member] | U.S. Agency Securities [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 24,592 | 27,534 |
Long-term Investments [Member] | Government Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 22,994 | 31,971 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 4 | 77 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | (197) | (12) |
Available-for-sale Securities | 22,801 | 32,036 |
Long-term Investments [Member] | Government Bonds [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 22,801 | 32,036 |
Long-term Investments [Member] | Corporate Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 228,406 | 295,921 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 322 | 715 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | (795) | (266) |
Available-for-sale Securities | 227,933 | 296,370 |
Long-term Investments [Member] | Corporate Bonds [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 227,933 | 296,370 |
Long-term Investments [Member] | Municipal Bonds [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 41,592 | 30,090 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 52 | 28 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | (57) | (32) |
Available-for-sale Securities | 41,587 | 30,086 |
Long-term Investments [Member] | Municipal Bonds [Member] | Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | 41,587 | 30,086 |
Long-term Investments [Member] | Other Long-term Investments [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis | 3,282 | 3,002 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 377 | 366 |
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | 0 | 0 |
Available-for-sale Securities | 3,659 | 3,368 |
Long-term Investments [Member] | Other Long-term Investments [Member] | Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investments, Noncurrent, Fair Value Disclosure | $ 377 | $ 366 |
Property, Plant and Equipment39
Property, Plant and Equipment (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | $ 747,779 | $ 694,183 |
Less: accumulated depreciation | (276,684) | (250,527) |
Property, Plant And Equipment, Net | 471,095 | 443,656 |
Land [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | 43,270 | 43,325 |
Building [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | 276,916 | 251,700 |
Leasehold Improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | 61,626 | 60,480 |
Machinery and Equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | 94,917 | 88,943 |
Computer Systems and Software [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | 162,883 | 154,291 |
Furniture and Fixtures [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | 27,735 | 26,900 |
Equipment Leased to Other Party [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | 73,912 | 35,968 |
Construction in Progress [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant And Equipment, Gross | $ 6,520 | $ 32,576 |
Goodwill and Intangible Asset40
Goodwill and Intangible Assets Goodwill Rollforward (Details) $ in Thousands | 6 Months Ended |
Mar. 31, 2017USD ($) | |
Goodwill [Roll Forward] | |
Balance at September 26, 2014 | $ 309,616 |
Translation adjustments | (865) |
Balance at September 30, 2016 | $ 308,751 |
Goodwill and Intangible Asset41
Goodwill and Intangible Assets Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Mar. 31, 2017 | Apr. 01, 2016 | Jan. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | Sep. 30, 2016 | |
Finite-Lived Intangible Assets [Line Items] | ||||||
Cost | $ 378,053 | $ 378,053 | $ 373,361 | |||
Accumulated Amortization | (174,330) | (174,330) | (158,019) | |||
Total | 203,723 | 203,723 | 215,342 | |||
Purchases of intangible assets | $ 5,250 | $ 105,270 | 5,250 | $ 105,270 | ||
Weighted average useful life | 18 years | 9 years | ||||
Amortization of Intangible Assets | $ 8,400 | $ 8,200 | 16,800 | 16,700 | ||
Acquired Patents And Technology [Member] | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Cost | 298,556 | 298,556 | 293,824 | |||
Accumulated Amortization | (115,122) | (115,122) | (101,711) | |||
Total | 183,434 | 183,434 | 192,113 | |||
Purchases of intangible assets | $ 105,000 | |||||
Weighted average useful life | 9 years | |||||
Customer Relationships [Member] | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Cost | 56,803 | 56,803 | 56,821 | |||
Accumulated Amortization | (37,006) | (37,006) | (34,113) | |||
Total | 19,797 | 19,797 | 22,708 | |||
Other Intangibles [Member] | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Cost | 22,694 | 22,694 | 22,716 | |||
Accumulated Amortization | (22,202) | (22,202) | (22,195) | |||
Total | $ 492 | $ 492 | $ 521 |
Goodwill and Intangible Asset42
Goodwill and Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Sep. 30, 2016 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Remainder of 2017 | $ 14,076 | |
2,018 | 25,592 | |
2,019 | 25,008 | |
2,020 | 24,545 | |
2,021 | 24,518 | |
Thereafter | 89,984 | |
Total | $ 203,723 | $ 215,342 |
Stockholders' Equity And Stoc43
Stockholders' Equity And Stock-Based Compensation (Narrative) (Details) - USD ($) | Apr. 26, 2017 | Jan. 25, 2017 | Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | Oct. 31, 2010 | Mar. 28, 2014 | Sep. 30, 2016 | Oct. 31, 2014 | Feb. 29, 2012 | Jul. 31, 2011 | Jul. 31, 2010 | Nov. 30, 2009 |
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Options outstanding to purchase | 8,690,000 | |||||||||||||
Year end stock price | $ 52.41 | |||||||||||||
Percentage of vesting per year | 50.00% | |||||||||||||
Common stock, dividends declared (in dollars per share) | $ 0.14 | $ 0.14 | $ 0.12 | $ 0.28 | $ 0.24 | |||||||||
Remaining authorization to purchase additional shares | $ 201,900,000 | $ 201,900,000 | ||||||||||||
Authorization Amount | 1,300,000,000 | 1,300,000,000 | $ 250,000,000 | |||||||||||
Subsequent Event [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Common stock, dividends declared (in dollars per share) | $ 0.14 | |||||||||||||
Employee Stock Option [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Stock options expected to vest | $ 39,000,000 | $ 39,000,000 | ||||||||||||
Employee stock options expected to be recognized over a weighted-average period | 2 years 6 months | |||||||||||||
Performance-Based Stock Options [Member] | Executive Officer [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 276,199 | 419,623 | ||||||||||||
Performance-Based Stock Options [Member] | Executive Officer [Member] | Awarded Fiscal 2016 [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Options outstanding to purchase | 397,748 | 397,748 | ||||||||||||
Performance-Based Stock Options [Member] | Executive Officer [Member] | Awarded Fiscal 2017 [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Options outstanding to purchase | 276,199 | 276,199 | ||||||||||||
Restricted Stock Units (RSUs) [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Stock options expected to vest | $ 90,500,000 | $ 90,500,000 | ||||||||||||
Employee stock options expected to be recognized over a weighted-average period | 2 years 9 months 18 days | |||||||||||||
Restricted Stock Units (RSUs) [Member] | Employees and Officers [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 4 years | |||||||||||||
Restricted Stock Units (RSUs) [Member] | Awards Granted Prior to November 2010 [Member] | Directors [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | 1 year | ||||||||||||
Restricted Stock Units (RSUs) [Member] | Awards Granted After November 2010 [Member] | Directors [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 2 years | |||||||||||||
Awards Granted Under 2005 Stock Plan Prior To February 2011 [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Terms for issuance of stock | 2 | |||||||||||||
Awards Granted Under 2005 Stock Plan From February 2011 [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Terms for issuance of stock | 1.6 | |||||||||||||
Employee Stock Purchase Plan [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Percentage of compensation withheld by employees to purchase common stock | 10.00% | |||||||||||||
Common stock purchase price determined over percentage of closing price | 15.00% | |||||||||||||
Additional Stock Approved [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Authorization Amount | $ 200,000,000 | $ 200,000,000 | $ 100,000,000 | $ 250,000,000 | $ 300,000,000 | |||||||||
Class A Common Stock [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Common stock, shares authorized (shares) | 500,000,000 | 500,000,000 | 500,000,000 | |||||||||||
Common stock, shares issued (shares) | 57,702,863 | 57,702,863 | 57,018,362 | |||||||||||
Common stock, shares outstanding (shares) | 57,702,863 | 57,702,863 | 57,018,362 | |||||||||||
Class A Common Stock [Member] | 2005 Stock Plan. [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Shares authorized under plan | 46,000,000 | 46,000,000 | ||||||||||||
Options outstanding to purchase | 10,013,000 | 10,013,000 | ||||||||||||
Weighted average remaining contractual life | 7 years 1 month 6 days | |||||||||||||
Options vested and exercisable | 5,195,000 | 5,195,000 | ||||||||||||
Class A Common Stock [Member] | Employee Stock Purchase Plan [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Maximum value of common stock available for eligible employees | $ 25,000 | |||||||||||||
Maximum number of common stock available for eligible employees | 1,000 | |||||||||||||
Purchase period | 6 months | |||||||||||||
Look back commencement period | 1 year | |||||||||||||
Class B Common Stock [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Common stock, shares authorized (shares) | 500,000,000 | 500,000,000 | 500,000,000 | |||||||||||
Common stock, shares issued (shares) | 44,073,597 | 44,073,597 | 44,403,847 | |||||||||||
Common stock, shares outstanding (shares) | 44,073,597 | 44,073,597 | 44,403,847 | |||||||||||
Options Granted Prior To June 2008 [Member] | Employee Stock Option [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 4 years | |||||||||||||
Options expiration period | 10 years | |||||||||||||
Options Granted From June Two Thousand Eight Member | Employee Stock Option [Member] | ||||||||||||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 36 months | |||||||||||||
Percentage of stock option becoming exercisable subjected to date of grant | 25.00% |
Stockholders' Equity And Stoc44
Stockholders' Equity And Stock-Based Compensation (Summary Of Stock Options Issued To Officers, Directors, And Employees Under 2000 Stock Incentive Plan And 2005 Stock Plan) (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 6 Months Ended |
Mar. 31, 2017USD ($)$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Document Period End Date | Mar. 31, 2017 |
Shares | |
Shares, Options outstanding at beginning of period | shares | 8,690 |
Shares, Grants | shares | 1,959 |
Shares, Exercises | shares | (567) |
Shares, Forfeitures and cancellations | shares | (69) |
Shares, Options vested and expected to vest | shares | 9,268 |
Weighted-Average Exercise Price | |
Weighted Average Exercise Price, Options outstanding at beginning of period | $ 35.98 |
Weighted Average Exercise Price, Grants (in usd per share) | 46.05 |
Weighted Average Exercise Price, Exercises (in usd per share) | 33.06 |
Weighted Average Exercise Price, Forfeitures and cancellations (in usd per share) | 37.70 |
Weighted Average Exercise Price, Options outstanding at end of period | 38.10 |
Weighted Average Exercise Price, Options vested and expected to vest (in usd per share) | 37.84 |
Weighted Average Exercise Price, Options exercisable (in usd per share) | $ 35.55 |
Weighted Average Remaining Contractual Life, Options vested and expected to vest at end of period | 7 years |
Weighted Average Remaining Contractual Life, Options exercisable | 6 years |
Aggregate Intrinsic Value, Options outstanding | $ | $ 143,411 |
Aggregate Intrinsic Value, Options vested and expected to vest | $ | 135,212 |
Aggregate Intrinsic Value, Options exercisable | $ | $ 87,726 |
Employee Stock Option [Member] | Options Granted From June Two Thousand Eight Member | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Share Based Compensation Arrangement By Share Based Payment Award Options Becoming Exercisable | 25.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 36 months |
Stockholders' Equity And Stoc45
Stockholders' Equity And Stock-Based Compensation (Summary Of Restricted Stock Units Issued To Officers, Directors, And Employees Under 2005 Stock Incentive Plan) (Details) shares in Thousands | 6 Months Ended |
Mar. 31, 2017$ / sharesshares | |
Shares | |
Shares, Non-vested at beginning of period | shares | 2,872 |
Shares, Granted | shares | 1,091 |
Shares, Vested | shares | (1,000) |
Shares, Forfeitures | shares | (63) |
Shares, Non-vested at end of period | shares | 2,900 |
Weighted-Average Grant Date Fair Value | |
Weighted Average Fair Value, Non-vested at beginning of period | $ / shares | $ 40.16 |
Weighted Average Fair Value, Granted | $ / shares | 46.15 |
Weighted Average Fair Value, Vested | $ / shares | 36.24 |
Weighted Average Fair Value, Forfeitures | $ / shares | 39.18 |
Weighted Average Fair Value, Non-vested at end of period | $ / shares | $ 43.79 |
Stockholders' Equity And Stoc46
Stockholders' Equity And Stock-Based Compensation (Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions) (Details) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Stockholders' Equity And Stock-Based Compensation [Abstract] | ||||
Document Period End Date | Mar. 31, 2017 | |||
Expected life (in years) | 5 years 1 month 17 days | 5 years 2 months 27 days | 5 years 1 month 17 days | 5 years 2 months 27 days |
Risk-free interest rate | 1.90% | 1.50% | 2.10% | 1.70% |
Expected stock price volatility | 27.00% | 30.10% | 27.50% | 29.80% |
Dividend yield | 1.20% | 1.40% | 1.10% | 1.40% |
Stockholders' Equity And Stoc47
Stockholders' Equity And Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Plan) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Document Period End Date | Mar. 31, 2017 | |||
Stock-based compensation expense | $ 15,983 | $ 16,086 | $ 33,198 | $ 35,466 |
Share-based Compensation | 33,198 | 35,466 | ||
Benefit from income taxes | (4,635) | (4,706) | (9,663) | (10,412) |
Total stock-based compensation, net of tax | 11,348 | 11,380 | 23,535 | 25,054 |
Stock Option [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | 4,575 | 4,998 | ||
Share-based Compensation | 9,378 | 11,364 | ||
Restricted Stock Units (RSUs) [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | 10,514 | 10,267 | ||
Share-based Compensation | 22,097 | 22,343 | ||
Employee Stock Purchase Plan [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | 894 | 821 | ||
Share-based Compensation | 1,723 | 1,759 | ||
Cost of Sales [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | 223 | 219 | 481 | 499 |
Cost Of Service [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | 123 | 114 | 257 | 243 |
Research and Development Expense [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | 4,506 | 4,268 | 9,436 | 9,375 |
Selling and Marketing Expense [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | 6,509 | 6,441 | 13,376 | 14,151 |
General and Administrative Expense [Member] | ||||
Stockholders' Equity And Stock-Based Compensation [Line Items] | ||||
Stock-based compensation expense | $ 4,622 | $ 5,044 | $ 9,648 | $ 11,198 |
Stockholders' Equity And Stoc48
Stockholders' Equity And Stock-Based Compensation (Schedule of Stock-Based Compensation By Classification) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | $ 15,983 | $ 16,086 | $ 33,198 | $ 35,466 |
Benefit from income taxes | (4,635) | (4,706) | (9,663) | (10,412) |
Total stock-based compensation, net of tax | 11,348 | 11,380 | 23,535 | 25,054 |
Cost of products [Member] | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 223 | 219 | 481 | 499 |
Cost of services [Member] | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 123 | 114 | 257 | 243 |
Research and development [Member] | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 4,506 | 4,268 | 9,436 | 9,375 |
Sales and marketing [Member] | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 6,509 | 6,441 | 13,376 | 14,151 |
General and administrative [Member] | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | $ 4,622 | $ 5,044 | $ 9,648 | $ 11,198 |
Stockholders' Equity And Stoc49
Stockholders' Equity And Stock-Based Compensation (Tax Benefit from Exercise of Options) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||
Document Period End Date | Mar. 31, 2017 | |||
Tax Benefit - stock option exercises & shares issued under ESPP | $ 95 | $ 28 | $ 419 | $ 123 |
Stockholders' Equity And Stoc50
Stockholders' Equity And Stock-Based Compensation (Stock Repurchase Authorizations) (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Jan. 25, 2017 | Oct. 31, 2014 | Feb. 29, 2012 | Jul. 31, 2011 | Jul. 31, 2010 | Nov. 30, 2009 |
Equity, Class of Treasury Stock [Line Items] | |||||||
Authorization Amount | $ 1,300,000 | $ 250,000 | |||||
Additional Stock Approved [Member] | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Authorization Amount | $ 200,000 | $ 200,000 | $ 100,000 | $ 250,000 | $ 300,000 |
Stockholders' Equity And Stoc51
Stockholders' Equity And Stock-Based Compensation (Stock Repurchase) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Dec. 30, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Stockholders' Equity And Stock-Based Compensation [Abstract] | ||||
Shares repurchased (in shares) | 519,917 | 531,465 | 1,051,382 | |
Cost | $ 24,999 | $ 25,001 | $ 50,000 | $ 76,856 |
Average Price Paid per Share (in dollars per share) | $ 48.07 | $ 47.02 | $ 48.07 |
Stockholders' Equity and Stoc52
Stockholders' Equity and Stock-Based Compensation - Dividends (Details) - USD ($) $ / shares in Units, $ in Millions | Apr. 26, 2017 | Jan. 25, 2017 | Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 |
Dividends Payable [Line Items] | ||||||
Common stock, dividends declared (in dollars per share) | $ 0.14 | $ 0.14 | $ 0.12 | $ 0.28 | $ 0.24 | |
Dividend Payment | $ 14.3 | |||||
Subsequent Event [Member] | ||||||
Dividends Payable [Line Items] | ||||||
Common stock, dividends declared (in dollars per share) | $ 0.14 | |||||
Dividend Payment | $ 14.3 |
Accumulated Other Comprehensi53
Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||
Balance, Beginning Of Period | $ (19,679) | $ (12,923) | $ (10,197) | $ (11,462) |
Income Tax Effect - Benefit/(Expense) | (698) | (249) | (669) | (293) |
Net Of Tax | 4,977 | 4,325 | (4,544) | 2,764 |
Realized (Gains) - Investment Securities | (12) | 347 | (34) | (478) |
Income Tax Effect - (Benefit)/Expense | 6 | (91) | (1) | (122) |
Net Of Tax | (6) | 256 | (33) | 356 |
Other Comprehensive Income (Loss), After Reclassifications, Net of Tax | 4,971 | 4,581 | (4,511) | 3,120 |
Balance, End Of Period | (14,708) | (8,342) | (14,708) | (8,342) |
Unrealized Gains/Losses On Available-For-Sale Securities [Member] | ||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||
Balance, Beginning Of Period | (1,277) | (510) | 350 | |
Unrealized Gains (Losses) | 686 | 1,401 | (1,474) | 242 |
Income Tax Effect - Benefit/(Expense) | (99) | (94) | (3) | (105) |
Net Of Tax | 587 | 1,307 | (1,471) | 347 |
Realized (Gains) - Investment Securities | (12) | 347 | (34) | (478) |
Income Tax Effect - (Benefit)/Expense | 6 | (91) | (1) | (122) |
Net Of Tax | (6) | 256 | (33) | 356 |
Other Comprehensive Income (Loss), After Reclassifications, Net of Tax | 581 | 1,563 | (1,438) | 703 |
Balance, End Of Period | (696) | 1,053 | (696) | 1,053 |
Foreign Currency Translation Adjustments [Member] | ||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||
Balance, Beginning Of Period | (18,402) | (12,413) | (11,812) | |
Unrealized Gains (Losses) | 4,989 | 3,173 | (3,739) | 2,229 |
Income Tax Effect - Benefit/(Expense) | (599) | (155) | (666) | (188) |
Net Of Tax | 4,390 | 3,018 | (3,073) | 2,417 |
Net Of Tax | 3,073 | (2,417) | ||
Other Comprehensive Income (Loss), After Reclassifications, Net of Tax | 4,390 | 3,018 | ||
Balance, End Of Period | $ (14,012) | $ (9,395) | $ (14,012) | $ (9,395) |
Per Share Data (Details)
Per Share Data (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Schedule Of Earnings Per Share Basic And Diluted [Line Items] | ||||
Document Period End Date | Mar. 31, 2017 | |||
Net income attributable to Dolby Laboratories, Inc. | $ 50,590 | $ 67,398 | $ 103,964 | $ 98,299 |
Weighted average shares outstanding-basic | 101,787 | 100,456 | 101,635 | 100,600 |
Potential common shares from options to purchase common stock | 1,513 | 748 | 1,448 | 674 |
Potential common shares from restricted stock units | 583 | 351 | 784 | 442 |
Weighted average shares outstanding-diluted | 103,883 | 101,555 | 103,867 | 101,716 |
Net income per share attributable to Dolby Laboratories, Inc. - Basic (in usd per share) | $ 0.50 | $ 0.67 | $ 1.02 | $ 0.98 |
Net income per share attributable to Dolby Laboratories, Inc. - Diluted (in usd per share) | $ 0.49 | $ 0.66 | $ 1 | $ 0.97 |
Employee Stock Option [Member] | ||||
Schedule Of Earnings Per Share Basic And Diluted [Line Items] | ||||
Anti-dilutive securities, excluded from calculations (in shares) | 1,819 | 7,124 | 1,222 | 6,349 |
Restricted Stock Units (RSUs) [Member] | ||||
Schedule Of Earnings Per Share Basic And Diluted [Line Items] | ||||
Anti-dilutive securities, excluded from calculations (in shares) | 2 | 733 | 8 | 184 |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | Sep. 30, 2016 | |
Income Tax Disclosure [Abstract] | |||||
Unrecognized tax benefits, gross | $ 87.4 | $ 87.4 | $ 75.2 | ||
Unrecognized tax benefits if recognized, would affect our effective tax rate | $ 75.3 | $ 75.3 | $ 62.1 | ||
Effective tax rate (as a percent) | 23.00% | 19.00% | 22.00% | 20.00% |
Income Taxes (Withholding Taxes
Income Taxes (Withholding Taxes) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2017 | Apr. 01, 2016 | Mar. 31, 2017 | Apr. 01, 2016 | |
Income Tax Disclosure [Abstract] | ||||
Withholding taxes | $ 13,408 | $ 12,406 | $ 22,399 | $ 22,188 |
Commitments And Contingencies57
Commitments And Contingencies (Schedule Of Contractual Obligations And Commitments) (Details) $ in Thousands | Mar. 31, 2017USD ($) |
Other Commitments [Line Items] | |
Naming rights, Remainder of Fiscal 2014 | $ 0 |
Naming rights, Fiscal 2015 | 7,715 |
Naming rights, Fiscal 2016 | 7,811 |
Naming rights, Fiscal 2017 | 7,909 |
Naming rights, Fiscal 2018 | 8,008 |
Naming rights, Thereafter | 94,972 |
Naming rights, Total | 126,415 |
Donation commitments, Remainder of Fiscal 2015 | 0 |
Donation commitments, Fiscal 2016 | 6,300 |
Donation commitments, Fiscal 2017 | 322 |
Donation commitments, Fiscal 2018 | 322 |
Donation commitments, Fiscal 2019 | 122 |
Donation commitments, Thereafter | 1,013 |
Donation commitments, Total | 8,079 |
Operating Leases, Future Minimum Payments Due, Next Twelve Months | 8,030 |
Operating leases, Fiscal 2015 | 14,411 |
Operating leases, Fiscal 2016 | 11,865 |
Operating leases, Fiscal 2017 | 11,108 |
Operating leases, Fiscal 2018 | 9,809 |
Operating leases, Thereafter | 33,520 |
Operating leases, Total | 88,743 |
Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months | 7,579 |
Purchase obligation, Fiscal 2015 | 8,300 |
Purchase obligation, Fiscal 2016 | 24,289 |
Purchase Obligation, Fiscal 2017 | 21,010 |
Unrecorded Unconditional Purchase Obligation, Due within Five Years | 0 |
Unrecorded Unconditional Purchase Obligation, Due after Five Years | 0 |
Purchase obligation, Total | 61,178 |
Total, due in Remainder of Fiscal 2014 | 15,609 |
Total, due in Fiscal 2015 | 36,726 |
Total, due in Fiscal 2016 | 44,287 |
Total, due in Fiscal 2017 | 40,349 |
Total, due in Fiscal 2018 | 17,939 |
Total, due Thereafter | 129,505 |
Total due | $ 284,415 |
Commitments And Contingencies58
Commitments And Contingencies (Narrative) (Details) | 12 Months Ended |
Sep. 27, 2013 | |
Commitments and Contingencies Disclosure [Abstract] | |
Term of agreement | 20 years |
Subsequent Events (Narrative) (
Subsequent Events (Narrative) (Details) $ in Millions | Mar. 31, 2017USD ($) |
Subsequent Event [Line Items] | |
Remaining authorization to purchase additional shares | $ 201.9 |